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Summary 
 
Epidemiological data strongly suggest that an unfavorable intrauterine environment may be 
highly predictive for the risk to develop diseases such as hypertension and the metabolic 
syndrome (“Fetal origin hypothesis” or Barker Hypothesis (Barker, Osmond et al. 1989). 
While this correlation has been demonstrated in different populations, the mechanisms 
underlying this phenomenon are under ongoing investigation. It is hypothesized that 
intrauterine environmental factors permanently alter gene expression via imprinting 
mechanisms during sensitive periods of fetal development leading to permanent alteration of 
the balance and function of endocrine systems.  
Two endocrine systems, predominantly involved in the adjustment of the organism towards 
increased strain, namely the hypothalamo-pituitary-adrenal (HPA) axis and the sympathetic 
nervous system (SNS) are believed to be sensitive towards imprinting during intrauterine life. 
These two systems represent putative key candidates to be involved in the intrauterine 
programming of the metabolic syndrome. Indeed, at the time of their own development, these 
systems are already challenged if adverse intrauterine conditions are present. Later in 
adulthood, the same systems are actively involved in the pathogenesis of hypertension and the 
metabolic syndrome. Therefore, it is speculated and animal models provide strong evidence 
that these systems may undergo developmental alterations during adverse intrauterine 
conditions leading to permanent changes in their physiological balance and reactivity towards 
demand.  
 
Our research has focused on the question whether adverse intrauterine conditions activating 
the human fetal stress systems have programming effects on these systems. Therefore, we 
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studied two typical, frequently occurring situations of an interference with the function of the 
human HPA-axis and SNS: 
First, fetal growth restriction, resulting mainly from placental insufficiency, exposes the fetus 
to stress and consecutively to an activation of the HPA-axis and the SNS and second, the 
iatrogenic application of synthetic corticosteroids in pregnancies at risk for preterm delivery 
to promote fetal lung maturation suppresses the fetal HPA-axis. Both stimuli alter the fetal 
HPA-axis regulation at a sensitive time in development and may entail long-term 
consequences for the fetus. We hypothesized that an intrauterine malprogramming of the fetal 
HPA-axis and/or the SNS  occurs in placental insufficiency and intrauterine corticosteroid 
application. To test this hypothesis we conducted our studies in human neonates when the 
influence of placental insufficiency and short term iatrogenic corticosteroid application were 
no longer present. We analyzed cortisol and cortisone levels from newborn salivary which is 
an established method to study HPA axis activity. Furthermore, we analyzed 24h holter ECG 
tracings for various frequency- and time domain parameters of heart rate variability and 
electrophysiological findings were supplemented by salivary α-amylase measurements as 
surrogate for cardiac autonomic regulation. 
 
Our first studies analyzed the effect of intrauterine fetal malnutrition as reflected by small for 
gestational age (SGA) neonates. For this purpose we measured cortisol levels of newborns at 
the 4th day of life before and after the heel-prick test which is an established stressor for 
neonates. Interestingly, we found a distinct suppression of HPA axis reactivity in SGA 
neonates in response to the stress event. Our finding provide evidence for a dysfunction of the 
ability for SGA neonates to adequately react to a stressful environment and suggests that the 
HPA axis may undergo permanent alteration during adverse intrauterine conditions. 
In contrast to our findings for the HPA axis, analysis of the cardiac SNS did not exhibit any 
alteration in the cardiac sympathetic-parasympathetic balance. In fact, all electrophysiological 
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parameters for time- and frequency domain analysis were comparable to control infants and 
α-amylase levels were not significantly different. Accordingly, the balance of the cardiac SNS 
appears to be preserved in the neonatal period of SGA infants thus making an intrauterine re-
setting of this system rather unlikely. 
 
Our next step was to analyze whether exogenous glucocorticoids may have the same effect on 
fetal HPA and SNS axis development as intrauterine growth restriction induced interference 
with the HPA axis. Glucocorticoids have experimentally been shown to be actively involved 
in developmental steps and maturation of organ systems. Maternal application of synthetic 
glucocorticoids is utilized as a therapeutic procedure in pregnancies at risk for preterm 
delivery to promote fetal lung maturation thus reducing morbidity and mortality of preterm 
delivered infants significantly. Accordingly, we analyzed the HPA axis of neonates that had 
received a single course of antenatal betamethasone treatment at 24-34 weeks of gestation due 
to impending preterm delivery but ultimately continued the pregnancy near or to term. We 
found that a single course of betamethasone treatment between 24 and 34 weeks of gestation 
did result in a significant suppression of stress reactivity in healthy neonates more than 6 
weeks after treatment. Again, we analyzed parameters of cardiac SNS activity in these infants. 
Similar to SGA infants, these neonates exhibited a preserved cardiac SNS balance.  
 
From the results of our data it appears that intrauterine HPA axis development is vulnerable 
towards conditions that alter endogenous glucocorticoid homeostasis and these alterations 
persist into postnatal life thus suggesting a permanent imprinting of this system. In contrast, 
stress induced intrauterine activation of the SNS does not directly persist into postnatal life in 
SGA infants and neonatal sympatho-vagal balance after exogenous glucocorticoid treatment 
seems to be preserved. Thus, the HPA axis but not the SNS presents a prerequisite to be a 
regulatory system primarily involved in the intrauterine origin of adult diseases. 
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Identifying regulatory systems actively involved in the fetal origins hypothesis may provide 
options for early intervention and disease prevention. The early postnatal period provides a 
unique time window to identify permanently altered regulatory systems as potential targets 
because temporary activated mechanisms will normalize in response to a normal environment 
after birth. Besides, early childhood may still contain some degree of plasticity of these 
systems with putative options for intervention or re-programming. 
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Introduction 
 
The intrauterine and neonatal environment determines the vulnerability of the fetus to chronic 
diseases. This concept has been pioneered by Günter Dörner more than 30 years ago who 
provided evidence that certain hormone levels play a significant role in the developmental 
determination of the balance of neuroendocrine systems regulating fundamental functions of 
the organism. Accordingly, non-physiological hormone levels during vulnerable periods of 
system development have been suggested to result in the alteration of systems regulating basic 
needs for survival such as food intake, stress response and reproduction (Dorner 1983). 
Dörner introduced the term “perinatal programming” to describe the developmental 
determination of the functional ranges of these key regulating systems. This concept received 
wide international recognition after the group of David Barker and Nicholas Hales asserted, 
based on their epidemiological studies, that intrauterine growth was inversely related to 
cardiovascular and metabolic disease in later life, also known as “Barker hypothesis” (Barker, 
Osmond et al. 1989; Hales and Barker 1992; Barker 1998). Subsequently the term “fetal 
programming” was internationally established to describe the notion that certain conditions or 
events during fetal development cause sustained effects on cellular function and regulatory 
system balance that ultimately transform into long-term consequences for the organism. 
 
Adaptation of the organism to a certain environment during a period of developmental 
determination of functional ranges of regulatory systems may provide an evolutionary short-
term advantage in terms of reproduction if the perceived postnatal environment comes true 
but can be detrimental for long-term survival when postnatal conditions do not match the 
antenatal setting of biological systems. Albeit regulatory systems will maintain some degree 
of plasticity during life, the prevailing modification of systems may take place during early 
life. 
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In the animal, there are various examples for a favorable intrauterine adaptation to 
environmental conditions to improve survival. As such, the coat of the meadow vole at birth is 
thicker in the offspring born in autumn than in those born in spring in an experimental setting 
where in utero and nest temperatures are similar thus providing no intrauterine advantage (Lee 
and Zucker 1988). As a process of developmental plasticity, postnatal coat thickness has been 
determined in utero induced by maternally derived signals of day length (Lee, Spears et al. 
1989). Likewise, unfavorable intrauterine conditions have the potential to influence regulatory 
systems in order to provide an immediate survival advantage. As an example, in the condition 
of placental insufficiency, fetal demand exceeds maternal supply for oxygen and nutrition. To 
survive, the fetus has to adapt by adjusting energy distribution to organs important for 
survival and by reducing growth rate. If these events occur during a window of developmental 
plasticity of regulatory systems, the biological tradeoff, however, may be permanent 
alterations in the balance of these systems, ultimately not matching the predicted environment 
after birth. Indeed, intrauterine malnutrition has been related to the risk for hypertension, 
insulin resistance, type-2 diabetes and cardiovascular disease in later life (Gluckman, Hanson 
et al. 2008). 
 
Unfavorable intrauterine environment and the risk for metabolic and 
cardiovascular diseases 
 
The concept of an intrauterine origin of adult diseases derives from epidemiological studies 
that have linked fetal growth with common adult disorders. As such, Barker et al. (Barker, 
Winter et al. 1989) were the first to show that body weight at birth, a rough parameter for 
conditions during fetal life, was inversely correlated with the risk for men to die from 
cardiovascular disease in later life. They analyzed a cohort of 5654 men born in Hertfordshire, 
England, between 1911 and 1930. These findings were confirmed by a Swedish study in 
15000 men and women with a 97% follow up of at least 50 years that revealed an increase in 
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death rates from ischemic heart disease in individuals with birth weights within the lower 
quartiles as compared to the highest quartiles (Leon, Johansson et al. 2000). An American 
study retrospectively analyzed more than 70000 women as part of the Nurses study and found 
a strong association between self-reported birth weight and coronary heart disease and stroke 
(Rich-Edwards, Stampfer et al. 1997). Further studies (Frankel, Elwood et al. 1996; Frankel, 
Elwood et al. 1996; Martyn, Barker et al. 1996; Stein, Fall et al. 1996) with few exceptions 
(Vagero and Leon 1994; Hulman, Kushner et al. 1998) confirmed these findings. As such, the 
association of birth weight and cardiovascular disease could be reproduced in populations of 
different ethnic origin, age and sex (Osmond, Barker et al. 1993; Frankel, Elwood et al. 1996; 
Stein, Fall et al. 1996; Leon, Lithell et al. 1998). These findings appear to be independent 
from prematurity originated abnormal birth-weight (Barker, Osmond et al. 1993). 
Associations could also be found for blood pressure as major risk factor for cardiovascular 
disease. A systematic review of 80 studies including more than 400000 individuals found low 
birth weight and small head circumference as significant risk factor for an increase in systolic 
blood pressure (Huxley, Shiell et al. 2000). However, methodical considerations and 
confounding factors have been under debate (Huxley, Neil et al. 2002; Hardy, Sovio et al. 
2006). 
 
Similarly, evidence has been found for an association of an adverse intrauterine environment 
and impaired glucose tolerance, insulin resistance, type 2 diabetes and hyperlipidemia. (Hales, 
Barker et al. 1991; Newsome, Shiell et al. 2003; Davies, Smith et al. 2004; Lapidus, 
Andersson et al. 2008). The  group of Barker demonstrated in a collective of 438 men from 
the Hertfordshire collective born between 1920-1930 that lower birth weight was related to an 
increase in impaired glucose tolerance and non-insulin dependent diabetes (Hales, Barker et 
al. 1991). These findings were confirmed in different populations of men and women. As 
such, the prevalence of impaired glucose tolerance or diabetes fell from 27% in individuals 
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with a birth weight of 2.5 kg or less to 6%  who weighed more than 3.41 kg after adjusting for 
current body mass index (BMI) (Philipps, Barker et al. 1993). Similar results were found in a 
Dutch and American study (Ravelli, van der Meulen et al. 1998; Rich-Edwards, Colditz et al. 
1999) and confirmed in a large literature review (Newsome, Shiell et al. 2003). 
Subsequently, a wide range of diseases including schizophrenia and depression (Thompson, 
Syddall et al. 2001), osteoporosis (Dennison, Syddall et al. 2005) and obstructive pulmonary 
disorders (Villamor, Iliadou et al. 2009) have been suggested to be linked with poor fetal 
growth. 
 
Birth weight as risk factor for adult disease, however, appears to be U-shaped because large 
size at birth, as evidence for excessive energy supply, equally adds to the risk for metabolic 
disorders (Rich-Edwards, Colditz et al. 1999; Osmond and Barker 2000; Boney, Verma et al. 
2005) and probably to cancer (Okasha, Gunnell et al. 2002; Vatten, Maehle et al. 2002; 
McCormack, dos Santos Silva et al. 2003; Kajantie, Osmond et al. 2005). Furthermore, it is 
noteworthy to mention, that at least for the risk of impaired glucose tolerance and the 
metabolic syndrome, not only intrauterine - but also early postnatal conditions of nutritional 
supply appear to be highly relevant (Plagemann, Heidrich et al. 1992; Plagemann 2004; 
Plagemann 2006). 
 
All these associations have been shown to be largely independent from classical life-style risk 
factors such as smoking, body mass index (BMI) or sedentary life which add to the effect of 
birth weight. 
Thus, in contrast to the classic understanding of the development of “life-style” diseases 
where multifactorial disorders such as cardiovascular and diabetic diseases are influenced in 
the context of a complex genetic background by external factors during childhood, 
adolescence and adulthood (“life-style”), the fetal programming theory proposes a significant, 
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independent influence of conditions during fetal life on the later health status additional to 
postnatal environment and genetics (Figure 1). 
 
Fetal environment
Intrauterine adaptation of the organism
•neuroendocrine
•metabolic
•cellular
Intrauterine environmental conditioning
Genetic 
predisposition
Mature 
environment
Adult disease 
risk
 
 Figure 1: The concept of fetal origins of adult diseases 
 
 
Adverse intrauterine conditions that induce intrauterine programming 
 
Size at birth is not causal in the pathway to disease. Birth weight and other anthropometric 
indices are rather unspecific symptoms of interactions between the genomic background and 
environmental intrauterine conditions during fetal development. An important reason for a 
fetus not to reach its genetic growth potential is impaired oxygen and nutrient supply. Thus, 
various experimental animal models have been applied ranging from maternal dietary and 
protein restriction (Snoeck, Remacle et al. 1990; Blondeau, Garofano et al. 1999; Manning 
and Vehaskari 2001; Ozaki, Nishina et al. 2001) to reduced uteroplacental blood flow 
(Simmons, Templeton et al. 2001; Payne, Alexander et al. 2003) leading to impaired fetal 
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growth with the endpoint of cardiovascular, metabolic and endocrine abnormalities before and 
after birth. 
In the human, intrauterine growth restriction (IUGR) complicates approximately 5% of all 
pregnancies in developed countries (Vandenbosche and Kirchner 1998). Malfunction of the 
placenta due to disturbed trophoblasts spreading (Kaufmann, Black et al. 2003) is the leading 
cause for undernutrition in the developing fetus. The fetus survives by adaptation of 
metabolic, endocrine and cardiovascular systems by activating a sparing mechanism for 
optimal homeostasis under these conditions leading to preservation of key body organ 
functions relevant for survival but at the cost of energy consuming fetal- and organ growth 
(Bauer, Walter et al. 2003). The result is an infant at an increased risk for intrauterine growth 
restriction and the deleterious consequences such as intrauterine asphyxia or death. 
 
Excessive intrauterine growth represents the other end of an U-shaped birth weight risk curve 
for adult hypertension and the metabolic syndrome. Pathologic macrosomia in terms of 
intrauterine environment derives from excessive overnutrition of the fetus commonly caused 
by an altered glucose homeostasis of an adipose or diabetic mother leading to fetal 
hyperinsulinemia and fat deposition resulting in alterations of glucose and lipid metabolism 
(Catalano, Presley et al. 2009).  
 
Various insults during pregnancy with- or without significantly altering gross birth weight, 
however, may have the potential to affect the development of biologic homeostasis in the 
fetus. As such, maternal antenatal stress (Van den Bergh, Mulder et al. 2005), exposure to 
synthetic glucocorticoids (Seckl and Holmes 2007), altered diet or maternal smoking 
(Wideroe, Vik et al. 2003) all appear to have the potential to induce hypertension, insulin 
resistance and other symptoms of the metabolic syndrome. 
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Biological basis of intrauterine programming 
 
Adaptation of the developing organism to a certain environment can occur on different levels 
of the biological system involving cellular function profiles, organogenesis, altered tissue 
differentiation and endocrine mechanisms. There has been accumulating evidence within 
recent years that epigenetic mechanisms may play a key role in the transformation of these 
adaptive processes into permanent long term effects with putative transgenerational impact. 
 
Epigenetic mechanisms 
Epigenetics describes the process where DNA transcription is permanently modified without 
altering the  sequence of the nucleotids within the DNA molecule. This process is mainly 
mediated by methylation of CpG dinucleotids of the promoter regions of specific genes and 
by deacetylation resulting in altered histone packing of the chromatin controlling the access of 
transcription factors to the DNA sequence (Jaenisch and Bird 2003; Goldberg, Allis et al. 
2007) Furthermore, chromatin influencing non-coding RNA is believed to be involved in 
control of epigenetic mechanisms (Bernstein and Allis 2005). 
 
There is evidence that during cellular differentiation, epigenetic modification of gene 
expression through environmental conditions is possible and once established, leading to 
permanent alteration of tissue-specific gene expression that may even be heritable. Epigenetic 
mechanisms are gene- and cell type specific. As such, an altered p53 CpG gene methylation 
of the renal p53 promoter has been found in the rat as a result of uteroplacental insufficiency 
leading to increases in apoptosis and reduced nephron numbers in the full-term rat kidney 
(Pham, MacLennan et al. 2003). In the human, kidney size and nephron numbers are reduced 
in individuals born as SGA (Hughson, Farris et al. 2003; Schmidt, Chellakooty et al. 2005). A 
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low nephron number has been suggested to be involved in the intrauterine programming of 
hypertension (Schreuder and Nauta 2007). 
Bogdarina et al. (Bogdarina, Welham et al. 2007) were able to show in the rat model, that a 
maternal low protein diet significantly altered the methylation of the Angiotensin (AT 1b) 
receptor gene promoter resulting in increased receptor protein expression in the adrenal gland 
of the offspring leading to increased adrenal Angiotensin responsiveness. This effect has also 
been suggested to be involved in development of hypertension in the offspring.  
Furthermore, unbalanced maternal nutrition induces epigenetic alterations in the methylation 
status and expression of the glucocorticoid receptor and peroxisomal proliferator-activated 
receptor (PPAR) involved in metabolic processes in the rodent liver (Lillycrop, Phillips et al. 
2005). Histone deacetylation appears to contribute to the observed epigenetic effect of type 2 
diabetes programming. The pathogenesis of pancreatic β-cell failure in IUGR rats has been 
related to epigenetic induced permanent suppression of Pdx-1 expression, a gene playing a 
critical role in normal β-cell function (Simmons 2007). In addition, intrauterine malnutrition 
results in a significant reduction of pancreatic β-cell mass (Garofano, Czernichow et al. 1998; 
Reusens and Remacle 2006). 
Since epigenetic alteration of DNA expression is generally stable during mitosis, these 
modifications are maintained during life. Programming effects, however, may not become 
apparent until later in life, especially if they are involved in responses to later environmental 
challenges at a biological phase when compensating mechanisms collapse as a result of aging. 
 
Epigenetic mechanisms may not only act as mediators of developmental plasticity but may 
also induce a transgenerational transmission of intrauterine induced system alterations. As 
such, in the rat, protein restriction in the F 0 generation was able to induce an altered promoter 
methylation of hepatic genes in the F 2 generation (Burdge, Slater-Jefferies et al. 2007) and 
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antenatal glucocorticoid treatment transferred into elevated hepatic PEPCK and insulin levels 
in the 2nd generation (Drake, Walker et al. 2005). 
 
 
The role of glucocorticoids 
There is major experimental evidence that maternal as well as fetal glucocorticoids play a key 
role in prenatal programming and recent evidence suggests that these effects might at least in 
part be transferred through epigenetic mechanisms. The notion of the importance of 
glucocorticoids is further supported by their potency to promote maturational processes 
during organogenesis that can be induced by exogenous glucocorticoid administration as well 
(Bian, Seidler et al. 1992; Bian, Seidler et al. 1993; Cole, Blendy et al. 1995; Fowden 1995). 
Indeed, major physiologic systems involved in the development of hypertension and the 
metabolic syndrome are glucocorticoid sensitive targets during intrauterine development 
(Seckl and Meaney 2004; Drake, Tang et al. 2007).  
 
Programming effects of glucocorticoids can be simulated in the animal by administration of 
synthetic glucocorticoids with unhindered placental transfer or by blocking the placental 11-
beta hydroxysteroid dehydrogenase (HSD) -2. As in the IUGR placenta, biological potent 
maternal cortisol cannot be adequately converted to its inactive metabolite, cortisone, due to a 
decreased placental 11-beta HSD-2 capacity which acts as a placental barrier to maternal 
glucocorticoids (Dy, Guan et al. 2008).  
 
In the rat, maternal antenatal dexamethasone treatment results in elevated blood pressure in 
the offspring (Benediktsson, Lindsay et al. 1993; Woods and Weeks 2005). Likewise, 
hypertension during adulthood could be induced by maternal administration of 
dexamethasone in the sheep (Dodic, May et al. 1998; Dodic, Hantzis et al. 2002). 
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Interestingly, inhibition of increased maternal glucocorticoid synthesis during nutritional 
restriction by metyrapone treatment prevented development of hypertension in the offspring 
whereas glucocorticoid supplementation of these metyrapone treated dams restored the 
hypertensive effect (Langley-Evans 1997; Langley-Evans 1997). Hypertensive effects could 
also be induced by blocking the placental 11-beta-HSD-2 using carbenoxolone. These effects 
are proven to be glucocorticoid dependent as adrenalectomized dams would deliver 
normotensive offspring (Lindsay, Lindsay et al. 1996). The role of glucocorticoids could 
further be enforced by the finding that adrenalectomy in intrauterine “programmed” rats 
restored normal blood pressure levels (Gardner, Jackson et al. 1997).  
These glucocorticiod effects have been shown to be transferred in a number of organ systems 
including the renal system and the renin-angiotensin-aldosterone system (RAAS) (Ortiz, Quan 
et al. 2003; Wintour, Moritz et al. 2003; Dickinson, Walker et al. 2007; Shaltout, Figueroa et 
al. 2008) as well as the cardiovascular system (Molnar, Howe et al. 2003; Roghair, Segar et 
al. 2005; Hadoke, Lindsay et al. 2006; Atanasova, Wieland et al. 2008; Roghair, Miller et al. 
2008) and at the level of central nervous centers (Dodic, Peers et al. 1999).  
 
Glucocorticoids are also involved in programming of glucose tolerance and metabolism. 
Again in the rat as well as in the sheep model, persistent alterations in glucose and insulin 
levels have been found in adult offspring after increased endogenous or exogenous 
intrauterine glucocorticoid exposure (Lindsay, Lindsay et al. 1996; Nyirenda, Lindsay et al. 
1998; Moss, Sloboda et al. 2001; De Blasio, Dodic et al. 2007). Effects of carbenoxolone 
could similarly be prevented by maternal adrenalectomy confirming glucocorticoid 
dependency of these effects (Lindsay, Lindsay et al. 1996). Likewise, fat metabolism and 
adipositas can be glucocorticoid induced (Bispham, Gopalakrishnan et al. 2003; Cleasby, 
Kelly et al. 2003; Gnanalingham, Mostyn et al. 2005). Mechanisms include impaired 
pancreatic β-cell function (Shen, Seckl et al. 2003) and pancreatic development (Gesina, 
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Blondeau et al. 2006), altered expression of hepatic metabolic enzymes (Nyirenda, Lindsay et 
al. 1998) and glucose and fatty acid metabolism in the muscle and adipocyte (Budge, 
Gnanalingham et al. 2005; Wyrwoll, Mark et al. 2008).  
 
Modulation of glucocorticoid action is mediated through glucocorticoid receptors. Of note, 
the promoter region of the glucocorticoid receptor contains a transcriptionally active CpG 
region sensitive to methylation / demethylation. At the same time, glucocorticoids have a 
demethylating capacity (Zhavoronkova and Vaniushin 1987). Accordingly, glucocorticoid 
effects are suggested to induce epigenetic effects as well as are dependent on epigenetic 
control of the glucocorticoid receptor expression which occurs in a tissue specific manner 
(McCormick, Lyons et al. 2000; Thomassin, Flavin et al. 2001; Weaver, Cervoni et al. 2004). 
 
 
Involvement of neuroendocrine and neurohumoral systems 
 
Induction of biological long-term effects are most likely conferred by homeostasis regulating 
systems that are activated during adverse intrauterine conditions.  
Periods of unfavorable intrauterine conditions such as placental insufficiency lead to an 
activation of the organism´s stress systems, namely the hypothalamo-pituitary-adrenal (HPA) 
axis and the sympathetic nervous system (SNS). As a consequence, the developing fetus is 
exposed to increased levels of glucocorticoids and catecholamines mediating protective 
reactions of the organism. Thus, the HPA axis and the SNS are strong candidates to be 
involved in the programming as well as being programmed by these conditions. 
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The HPA axis: Target and mediator of intrauterine programming 
 
The HPA axis represents the organism´s central organ of stress regulation. Activation of the 
HPA axis leads to an increase in adrenal cortisol release thereby communicating 
environmental challenges to the fetus to optimize the organism for survival. Serum levels of 
cortisol have been shown to be significantly increased in human fetuses with IUGR 
(Economides, Nicolaides et al. 1988; Goland, Jozak et al. 1993). Increased levels of cortisol 
represent an important developmental challenge during organogenesis with tissue specific 
consequences as has been shown above. 
Increased cortisol levels of fetal as well as of maternal origin due to increased placental 
transfer in IUGR but also fetal exposure to synthetic glucocorticoids appear to have a 
considerable impact on regulation of the developing fetal HPA axis itself. 
As such, the HPA axis and its key limbic regulator, the hippocampus are especially sensitive 
to glucocorticoids as part of a tightly regulated feedback mechanism involving glucocorticoid 
receptors (GR) and mineralocorticoid receptors (MR) at the level of the hippocampus, 
hypothalamus and pituitary gland to inhibit HPA activity (Jacobson and Sapolsky 1991). 
Experiments in the rat have shown that intrauterine overexposure to glucocorticoids results in 
attenuated hippocampal GR and MR expression. The resulting permanently increased cortisol 
levels and hypertension in adulthood suggests an impaired negative feedback sensitivity of the 
HPA axis (Levitt, Lindsay et al. 1996). On the other hand, the amygdale, a center for anxiety 
and fear modulation that is interconnected with HPA axis dependent stress regulation via 
corticotrophin releasing hormone (CRH) signaling (Feldman and Weidenfeld 1998) is 
vulnerable to antenatal glucocorticoid excess as levels for CRH are permanently increased in 
the adult rat as well as GRs and MRs, pointing to an increased excitatory activity on the HPA 
axis (Welberg, Seckl et al. 2000; Welberg, Seckl et al. 2001). Likewise, the hypothalamus has 
been shown to express increased levels of CRH mRNA and protein after intrauterine 
undernutrition in the rat (Nunez, Ruiz et al. 2008) and GRs but not MRs have been found to 
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be permanently decreased in the hypothalamus and the pituitary gland (Bertram, Trowern et 
al. 2001; Hawkins, Hanson et al. 2001) (Figure 2). 
 
GR
MR
CRH
GR
MR
GR
MR –
CRH 
 
Figure 2 A possible schema of glucocorticoid (GR) and mineralocorticoid (MR) 
receptor programming of the HPA axis. Adapted from (Drake, Tang et al. 2007) 
 
Accordingly, permanent alterations of these receptors may induce a resetting of the balance 
and reactivity of the HPA axis in later life. Nevertheless, HPA axis regulation and 
programming is complex and far from being completely understood as factors such as gender 
(McCormick, Smythe et al. 1995), species specific differences (Matthews 2002) and different 
time windows for vulnerability of HPA axis development (Fowden, Giussani et al. 2005) 
further add to the complexity of the system. Of note, the GR appears to be susceptible to 
epigenetic alteration (Weaver 2007). 
In conclusion, the HPA axis is strongly involved in regulation of cardiocirculatory and 
metabolic homeostasis of the organism. Permanent alteration of its set-point and balance 
throughout life will ultimately impact adult health. As a matter of fact, elevated cortisol levels 
have been linked to arteriosclerosis and diabetes (Sapolsky, Romero et al. 2000). 
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The mutual dependence of the HPA axis and the sympathetic nervous system 
 
The HPA axis is closely interconnected with the sympathetic nervous system (SNS) and both 
are subject to environmental input during intrauterine life. As such, catecholaminergic 
neurons ascending from the medulla exert stimulatory effects on CRH neurons located in the 
hypothalamic paraventricular nucleus (PVN) via α1 adrenergic receptors (Herman, Prewitt et 
al. 1996). Furthermore, hippocampal corticoid receptor levels modulating glucocorticoid 
negative feedback are modified by catecholaminergic brainstem neurons (Barbazanges, 
Piazza et al. 1996). On the other hand, glucocorticoids provide direct signals for 
noradrenergic system maturation in the brainstem and thus on central noradrenergic activity 
(Slotkin, Lappi et al. 1992). Likewise, cardiac noradrenergic innervation is affected by 
glucocorticoids (Bian, Seidler et al. 1993).  
 
CRH neuron stimulation
(Nucleus perivertrikularis)
Corticosteriod receptor
modulation (Hippocampus)        
noradrenergic system
maturation, sensitivity, 
turnover, activity
Cardiac sympathetic
innervation
A+NA plasma levels
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nervous system
HPA - axis
Hippocampus
noradrenaline
adrenaline
cortisol
 
Figure 3 Interaction between the HPA –axis and the sympathetic nervous system 
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The sympathetic nervous system 
 
The SNS is, as the HPA axis, activated during periods of intrauterine strain (Economides, 
Nicolaides et al. 1991; Westgren, Lingman et al. 1997). On the other hand, adrenergic 
cardiovascular drive and noradrenergic influences play a key role in the development or 
progression of hypertension and the metabolic syndrome in the adult (Mancia, Bousquet et al. 
2007; Grassi, Arenare et al. 2009) 
The SNS is composed of multiple function-specific subunits (Janig and McLachlan 1992) and 
programming of sympathetic nervous system function is believed to occur regionally rather 
than on a global basis, suggesting that subdivisions of the sympathetic nervous system may be 
influenced by different sets of environmental variables (Young 2002). It has been suggested, 
that exposure dependent activation of specific sympathetic pathways during development may 
prevent these subdivisions to undergo nerve cell loss thereby determining the structure and 
function of the system (Young 2006).  
An increased resting pulse rate in adults with low birth weight has been suggested to be an 
imperfect measure of an activated SNS as a result of intrauterine system alteration (Phillips 
and Barker 1997; Flanagan, Vaile et al. 1999). Interestingly, pulse rate was inversely 
associated with insulin sensitivity in men pointing to the interconnection between sympathetic 
system activity and glucose metabolism (Flanagan, Vaile et al. 1999). Furthermore, markers 
of impaired fetal growth were related to autonomic cardiovascular control in adults involving 
modulation of both sympathetic and parasympathetic function (Ijzerman, Stehouwer et al. 
2003; Ward, Moore et al. 2004; Jones, Beda et al. 2007).  
 
Animal models with different experimental settings of intrauterine demand have been 
described to impact sympathoadrenergic system development that ultimately results in a 
characteristic phenotype during adulthood. As such, different forms of intrauterine stress, 
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such as hypoxia, environmental temperature, maternal glucose homeostasis and nutrition have 
the potential to permanently impact sympathetic system regulation or sympathetic innervation 
either directly or through indirect pathways such as glucocorticoid induced (Young 2006).  
It has been speculated, that an unfavorable intrauterine environment may be a stimulus to 
promote sympathetic hyperinnervation of fetal vessels and tissues or may enhance 
catecholamine turnover in developing sympathetic neurons (McMillen and Robinson 2005). 
Indeed, increased levels of noradrenaline were found in hypothalamic tissue of growth 
restricted female adult rats (Jansson and Lambert 1999) and an enhanced sympathetic 
innervation of arteries was observed in the chronically hypoxic chick embryo (Ruijtenbeek, le 
Noble et al. 2000). Furthermore, prenatal hypoxia lowered adult autonomic nervous activity in 
cardiac related structures such as the stellate ganglion, the heart and the adrenals. Albeit heart 
rate and mean arterial pressure during resting conditions did not significantly differ from 
control animals, during a stress test, these animals revealed a significant increase in heart rate 
and its variability (Peyronnet, Dalmaz et al. 2002). Others have found a significantly 
increased basal cardiac sympathetic neuronal activity in newborn growth restricted rats 
(Shaul, Cha et al. 1989) whereas persistent abnormalities of cardiac noradrenergic innervation 
was observed after exogenous glucocorticoid exposure (Bian, Seidler et al. 1993).  
In summary, the SNS appears to be susceptible to intrauterine influences that induce 
permanent alterations of its balance. This mechanism may therefore be relevant for the 
pathogenesis or progression of adult cardiovascular and metabolic diseases. 
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Conclusions and general aims of our studies 
 
The wealth of studies both in humans and animals that clearly indicate, that the intrauterine 
environment evolves as a significant determinant for future health or disease has led to a new 
understanding of the development of diseases of cardiovascular and metabolic origin that 
have previously been attributed in a large part to “life-style” influences. The newly 
established paradigm now placed the period of pregnancy at a prominent position of 
consideration with respect to public health issues and disease prevention and may have a large 
impact on socioeconomic issues. 
 
While epidemiologic evidence of this interconnection is overwhelming, the exact mechanisms 
involved in intrauterine imprinting are under extensive investigation. 
Two major regulatory units involved in stress regulation, namely the HPA-axis and the SNS, 
amid others, are studied extensively in various experimental settings of animal models. If 
indeed these systems would be permanently altered depending on their intrauterine 
environment, they may represent key elements for the individual risk profile of health. While 
models may confirm this hypothesis in the animal setting, there is considerably less data in 
humans. As a matter of fact, adults born small for gestational age (SGA) have been shown to 
have higher resting cortisol levels and an increased heart rate compared to control populations 
as evidence for HPA axis- and SNS activation (Flanagan, Vaile et al. 1999; Phillips, Walker 
et al. 2000). At the same time, these conditions are risk factors in the pathogenesis of 
cardiovascular and metabolic events. However, this does not automatically imply that the 
alteration of these systems is of intrauterine origin according to the hypothesis of fetal 
programming. Since the progression towards disease will involve action of primary- and 
reaction of compensatory systems, initial factors for disease development have to be identified 
if preventive measures or therapeutic strategies are to be developed. 
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According to these considerations, we conducted our studies in the human neonate for two 
major reasons: 1. To provide data on the human situation as animal models are hampered by 
the fact that developmental frames cannot always be easily transferred and 2. to analyze a 
period when temporary up-regulated systems normalize in response to a normal postnatal 
environment, whereas permanently altered systems may become apparent. Furthermore, this 
time point is interesting since compensatory system reactions may not have had the time to 
develop. 
If indeed the HPA axis and the SNS experience permanent alterations of intrauterine origin, 
they should be detectible already shortly after birth. 
Considering the fact that these alterations may be mild and clinically not apparent during 
early life due to a high compensatory reserve being only “exhausted” over many years, we 
aimed to not only analyze HPA and SNS balance under resting conditions but also to 
challenge these systems. 
Accordingly the following questions were formulated: 
 
1. Do neonates that are SGA exhibit alterations of HPA axis balance during resting or 
activated conditions that may be attributable to an intrauterine origin (Schaffer, 
Muller-Vizentini et al. 2009)? 
 
2. Are there signs for the cardiac subunit of the SNS to be shifted in the balance between 
sympathetic and parasympathetic activity in SGA neonates and may they be exposed 
during strain (Schaffer, Burkhardt et al. 2008)? 
 
3. If glucocorticoids play a significant role in the development and maturation of the 
HPA axis and the SNS, do exogenous synthetic glucocorticoids that are administered 
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as a standard procedure in pregnancies at risk for preterm delivery have the potential 
to disturb normal HPA axis and SNS development in a way that predisposes these 
infants to the risk of adult disease development (Schaffer, Luzi et al. 2009) + Schaffer, 
Burkhardt et al, submitted) 
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ABSTRACT: There is evidence that adverse conditions during
intrauterine development affect future health of the offspring. Hypo-
thalamus-pituitary-adrenal (HPA) axis dysregulation is assumed to
play an important role in the association of small for gestational age
(SGA) and the pathogenesis of hypertension and the metabolic
syndrome. Stress response patterns in SGA neonates may identify a
link with intrauterine-induced permanent maladaptation of the HPA
axis. Salivary cortisol and cortisone levels were therefore analyzed
during resting conditions and in response to a pain-induced stress
event in SGA (5th percentile) and appropriate for gestational age
(AGA) neonates born 34 wk of gestation. In AGA neonates,
salivary cortisol and cortisone levels significantly increased after the
stress event (p  0.05). In contrast, SGA infants exhibited a blunted
steroid release after stress induction (p  0.76, p  0.65, respec-
tively). No influence of mode of delivery (p  0.93), gender (p 
0.21), and gestational age (p  0.57) on stress response patterns was
observed in a multiple stepwise regression. SGA neonates show a
blunted physiologic activation of the HPA axis in response to a stress
stimulus. Thus, intrauterine-induced alteration of HPA axis regula-
tion seems to persist into the postnatal period and represents a
prerequisite for the hypothesis of HPA axis involvement in the fetal
origin of adult diseases. (Pediatr Res 65: 231–235, 2009)
Substantial evidence from epidemiologic data and experi-mental animal models indicate that stressful conditions
during intrauterine fetal life affect behavioral development and
future health of the offspring. Maladaptation of the fetal
autonomic regulation has been suggested as a putative predis-
posing factor in the pathogenesis of cardiovascular, metabolic,
and psychiatric diseases in low birth weight (LBW) infants
(1–3). This has been reinforced by the discovery of an early
programming of the stress response–mediating neuroendo-
crine system, namely the hypothalamic-pituitary-adrenal
(HPA) axis and the autonomic nervous system (4,5). As such,
LBW, a surrogate for fetal malnutrition has been linked with
increased adrenocortical hormone activity and activation of
the sympathetic nervous system (6–9) in childhood and adult
life in independent populations.
A pathophysiologic explanation of this phenomenon de-
scribed by Barker’s group as “fetal programming” (10) has
been derived from animal models revealing long-term changes
in the molecular expression of steroid receptors within the
limbic system (11).
Increases in glucocorticoids, such as cortisol and cortisone,
are generally considered as adaptive mechanisms to mobilize
energy for survival in response to a stressful event or to danger
(12). Prolonged intrauterine exposure to stress, however, may
lead to an alteration of the set point of the stress regulatory
system resulting in increased levels of cortisol that can nega-
tively effect the functioning of several biologic systems
(13,14) and ultimately result in arterial hypertension and
diabetes mellitus type II, one of the main risk factors for
arteriosclerosis-associated diseases.
Because patterns of stress response in early postnatal life
may help to identify prenatally induced alterations in the HPA
axis and simultaneously exclude an only temporarily activated
HPA axis due to adverse intrauterine conditions, we analyzed
the stress reactivity of the HPA axis in small for gestational
age (SGA) newborns. Our results provide evidence that the
HPA axis is already altered in SGA newborns and may, if
these alterations persist permanently, play a role in the intra-
uterine origin of adult diseases.
MATERIALS AND METHODS
Subjects. The study was approved by the Research Ethics Committee of
the University of Zurich and the Federal Ethics Commission of the Canton of
Zurich. Written maternal consent was obtained from all participants in the
study.
Saliva samples from 40 appropriate for gestational age (AGA) and 18 SGA
infants were analyzed. Approximately, 40 SGA infants after 34 wk of
gestation were born during the study period (April–September, 2005) in our
hospital with 2300 deliveries per year. Healthy controls were recruited until
approximately the double number of study patients was reached to obtain
adequate numbers for statistical evaluation. SGA was defined as birth weight
below the 5th percentile of the gender-specific newborn reference chart (15).
Birth weight between the 10th and 90th percentile was required for AGA
children. Only healthy newborns delivered after 34 wk of gestation (238 d)
were included in the study. Newborns requiring intensive care or those with
malformations were excluded from the study. Additional exclusion criteria
included maternal substance abuse (nicotine, alcohol) and exogenous corti-
costeroid treatment (e.g., for lung maturation induction) during pregnancy.
Sonographic measurements of fetal crown-rump length and biparietal diam-
eter during the first trimester served as parameters for accurate determination
of gestational age. In the SGA group, 10 infants had a diagnosis of intrauterine
growth restriction (IUGR) established either by serial sonographic biometry
or by pathologic Doppler measurements, one was SGA alone and 7 infants
were referred to our clinic for delivery only and did not receive antenatal care
at our institution. Sonographic data for the latter group were not available.
Experimental procedures. Salivary cortisol and cortisone levels were
collected between 72 and 96 h postnatal during a routine heel prick for the
Guthrie test (a newborn screening test for metabolic disorders). This was
considered to be the equivalent of a stress event. Although infants are born
Received June 11, 2008; accepted September 18, 2008.
Correspondence: Leonhard Scha¨ffer, M.D., Universita¨ts-Frauenklinik, Frauenklin-
ikstrasse 10, CH-8091 Zu¨rich, Switzerland; e-mail: leonhard.schaeffer@usz.ch
Abbreviations: AGA, appropriate for gestational age; HPA axis, hypothal-
amus-pituitary-adrenal axis; SGA, small for gestational age
0031-3998/09/6502-0231
PEDIATRIC RESEARCH
Vol. 65, No. 2, 2009
Copyright © 2009 International Pediatric Research Foundation, Inc.
Printed in U.S.A.
231
without a circardian rhythm and acquire it only within the first year of life
(16), saliva samples were collected only during the morning hours between
8 a.m. and 1 p.m. from each infant 10 min before and 20 min after the stress
event. Baseline levels were obtained in an undisturbed environment. The time
of collection was based on experiments revealing peak cortisol responses
between 20 and 30 min postmanipulation (17). To obtain the saliva, a cotton
swab was placed in the infants’ mouth for a duration of 5 min. Salivary
cortisol reflects the unbound, active fraction of cortisol and is highly corre-
lated with plasma cortisol levels (18,19). Samples were placed in saliva
collection tubes (Salivette, Sarstedt, Nu¨mbrecht, Germany) and frozen at
20°C until further analysis.
Cortisol/cortisone measurements. Saliva cortisol and cortisone were de-
termined simultaneously using liquid chromatography tandem mass spec-
trometry, with atmospheric pressure chemical ionization in the positive ion
mode, according to a modified method of Rauh et al. (20). One hundred
microliters of the samples and calibrators were deproteinized with methanol/
zinc sulfate (50 g/L, 1/1 vol/vol). After centrifugation, the supernatants were
applied to an online solid-phase extraction column with subsequent high-
performance liquid chromatography separation using column switching (ex-
traction column: Oasis HLB 2.1  20 mm, 15 m; Waters, Milford, MA).
The samples were washed with 5% methanol and eluted in back-flush with 2
mM ammonium acetate/methanol (30:70, vol/vol) onto the analytical column
(Chromolith RP 18e100  4.6 mm, Merck, Darmstadt, Germany) at a flow
rate of 1 mL/min. Sample analysis was performed in the multiple-reaction
monitoring mode with a dwell time of 150 ms per channel using the following
transitions for quantification (qualifier transition): m/z 363.2/121.2 (363.2/
309.4) cortisol, m/z 361.1/162.9 (361.1/239.0) cortisone, m/z 367.3/121.2
Cortisol-d4.
Statistical analysis. We applied STATA 9 Statistics/Data Analysis Soft-
ware (Stata Corporation, College Station, TX) for statistical analysis accord-
ing to Altman’s recommendations for repeated measurements (21). Baseline
characteristics of SGA and AGA infants were compared using the Mann–
Whitney test and 2 test when appropriate. Because basal levels of cortisol
vary considerably in individual newborns and children (17), absolute values
and relative alterations were analyzed. Cortisol and cortisone values were not
normally distributed as analyzed by the Shapiro-Francia W’ test. We therefore
analyzed the difference between cortisol and cortisone baseline levels and
time point “20 min post” using the Wilcoxon signed rank test. The Mann–
Whitney test was used for comparison of raw baseline cortisol and cortisone
levels. A stepwise multiple regression was applied to test for putative
influencing factors on cortisol alterations such as gestational age, birth weight
independent of gestational age, mode of delivery (vaginal/cesarean section),
and gender. To validate our statistical analyses, a power calculation was
conducted in SGA infants assuming the mean increase in cortisol levels of
AGA infants as relevant. Finally, cortisol and cortisone levels in AGA and
SGA infants were tested for correlation using the Spearman rank correlation
test. The level of statistical significance of all analyses was set at p  0.05.
RESULTS
The gestational ages of the AGA and SGA newborns were
comparable (median: 273 versus 266 d of gestation, respec-
tively, p  0.29). Median birth weight of the SGA children
was 2265 g corresponding to the 1.6th weight percentile
compared with 3288 g corresponding to the 52nd percentile in
the AGA group. A summary of the characteristics of the study
population is given in Table 1.
Median levels for basal cortisol and cortisone were compa-
rable in the AGA and SGA neonates (1.18 versus 0.95 ng/mL,
p  0.7; 11.35 versus 13.55 ng/mL, p  0.42, respectively).
Individual stress responses are illustrated in Figure 1a and b.
In AGA neonates, salivary levels of cortisol and cortisone
significantly increased after the stress stimulus (2.4 and 18.15
ng/mL, p  0.05, respectively). In contrast, the cortisol and
cortisone response in SGA neonates was noticeably blunted
(0.69 ng/mL, p  0.76 and 13.05 ng/mL, p  0.65, respec-
tively) (Fig. 2a and b). To validate the absent cortisol response
in SGA neonates a one-sample t test power calculation was
conducted for the given sample size (n  18) revealing a
power of 99% at a significance level of 0.05.
To test for a putative influence of gestational age, gender,
birth weight, and mode of delivery on cortisol stress response
patterns a multiple stepwise regression model was applied.
None of these factors were found to have a significant influ-
ence (p  0.574, p  0.207, p  0.347, p  0.927, respec-
tively, Table 2).
Table 1. Baseline characteristics
AGA SGA p
Gestational age (d) 273 (240–294) 266 (240–292) 0.289
Birth weight (g) 3288 (2100–3780) 2265 (1470–2870) 0.05
Weight percentile 52 (17.6–91.6) 1.6 (0.1–4.3) 0.05
Body length (cm) 49.5 (45–54) 45 (40–48) 0.05
Length percentile 65.2 (5.3–100) 3.85 (0–35.2) 0.05
Gender,
male/female
18/22 6/12 0.697
Delivery,
vaginal/cesarean
25/15 6/12 0.05
5-min APGAR
score
9 (8–10) 9 (8–10) 0.307
Maternal age (yr) 30 (18–39) 29 (19–39) 0.839
Parity 2 (1–4) 1 (1–4) 0.05
Values are medians with ranges in parentheses; n  40 appropriate for
gestational age (AGA) neonates and 18 small for gestational age (SGA)
neonates.
Figure 1. Salivary absolute levels for cortisol (a) and cortisone (b) including
individual courses of AGA (n  40) and SGA (n  18) newborns before
(baseline) and after (20 min post) application of the stress stimulus.
Figure 2. Mean relative salivary level alterations for cortisol (a) and corti-
sone (b) and SEM. In AGA newborns (n  40), cortisol and cortisone levels
significantly increase after stress induction (p 0.05). In SGA newborns (n
18), cortisol and cortisone levels do not significantly increase after application
of the stress stimulus (p  0.76, p  0.65, respectively).
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Finally, a Spearman rank correlation revealed a strong
correlation for cortisol and cortisone levels in AGA (R 0.77,
p  0.001) and in SGA (R  0.82, p  0.001) neonates, thus
excluding the possibility that decreased cortisol responses in
SGA neonates could be the result of an increased conversion
of cortisol to cortisone (22).
DISCUSSION
We have shown that the hypothalamic-pituitary-adrenal
(HPA) axis system of SGA neonates does not adequately react
in response to the application of a stress stimulus. Experiments
in fetal sheep showed that the cortisol responses to acute
stresses are often blunted during suboptimal intrauterine con-
ditions in late gestation (23). In the presence of adverse
intrauterine conditions, decreases in the mRNA content of
hypothalamic corticotrophin-releasing hormone, pituitary glu-
cocorticoid receptor, and adrenal ACTH (ACTH) receptor
have been found (11), which will impair feedback regulation
of the axis. These observations suggest that adverse intrauter-
ine conditions alter both the set point and sensitivity of the
fetal HPA axis. Alterations of the HPA axis activity in human
adults born SGA have been reported repeatedly. Thus, birth
weight has been shown to be inversely correlated with basal
cortisol levels in independent populations (9). Furthermore,
cortisol responses to pharmacological ACTH challenge
(24,25) and after psychosocial stress (26) were exaggerated in
adults born with LBW. Others, however, did not find a clear
inverse correlation between birth weight and HPA activity
(27). These inconsistent results may reflect large heterogene-
ities in the populations studied, often a mixture of premature
infants, infants with uncertain gestational ages, LBW fetuses,
fetuses with IUGR as well as different experimental settings.
Although the majority of studies in humans provide strong
evidence for an alteration of the HPA axis set point and
feedback in adults born SGA, these findings do not necessarily
represent etiologic factors involved in the concept of fetal
programming especially considering the interdependence of
the pituitary-adrenocortical response with other neuroendo-
crine regulatory systems. Moreover, the influence of environ-
mental factors on alterations of the HPA system remains
unknown, because this factor was not controlled in most of the
above-mentioned studies. To elucidate a putative intrauterine
induction of permanent alteration of the HPA-axis system
balance, we focused on HPA-axis activity and development in
the early postnatal period. In our study, we were able to
demonstrate that the stress response is altered in SGA neo-
nates on the 4th day of life. It is difficult to exactly define an
adverse intrauterine environment for the fetus. Fetuses with
IUGR are not necessarily SGA and the definition of IUGR
varies considerably in the literature. The definition of SGA is
unequivocal and is commonly referred to as a weight below
the 10th percentile for gestational age. If the definition thresh-
old is set low and fetuses with aneuploidies and infections are
excluded, a relatively homogenous population of fetuses ex-
periencing adverse intrauterine conditions is left. In our study,
we adopted a threshold for SGA definition as birth weight
below the 5th percentile. The median birth weight of the SGA
newborns in our study corresponds to the 1.6th percentile
defining a relatively homogeneous cohort of growth-restricted
neonates. The majority of epidemiologic studies have corre-
lated just LBW with the risk for hypertension (28). One may
expect an even more pronounced effect if only infants with
proven intrauterine compromise could have been included in
these studies.
A strength of our study population is that, in contrast to
most studies, maternal influencing factors, such as nicotine
and alcohol consumption during pregnancy, and antenatal
corticosteroid administration that have been shown to induce
growth restriction, but may at the same time have independent
effects on the HPA axis of the mother and child (29–34), have
all been excluded in our study.
The heel-prick test has been shown to be a significant stress
event for the newborn, resulting in HPA axis activation as
indicated by significantly increasing cortisol levels in response
to the test (35). We found a wide variation in cortisol levels
between individual infants. This variation has been observed
in other studies as well. Nonetheless, variations over time in
the same individual have not been shown to vary significantly
(17,36).
Few studies analyzed the activity of the human HPA axis in
the adolescent and perinatal period. In SGA children, in-
creased plasma and urinary glucocorticoid levels were found
at the age of 9 yr (37), others, however, did not observe a
correlation between basal serum cortisol levels and rhythms
during a 24-h period in 8–10-y-old children born SGA (38).
To our knowledge, the present study is the first to analyze
HPA reactivity in healthy human SGA neonates. Experiments
in neonates provide the possibility to study the persistence of
intrauterine-induced alteration of the HPA axis into the post-
natal period and to differentiate them from changes, which are
only transiently altered as a compensatory mechanism during
intrauterine undernutrition. At the same time, long-term ef-
fects resulting from these primary alterations do not yet have
the time to develop. Furthermore, the neonatal period may
represent an intermediate stage of HPA axis development still
susceptible to plastic changes.
The absent stress response in SGA neonates in our study
was rather surprising. A delay in the maturation of the HPA
system as a possible explanation is rather unlikely, because
premature AGA newborns at 34 wk of gestation already
display normal stress reactivity (31). Furthermore, maturation
of cerebral structures in SGA fetuses is considered to be rather
accelerated (39).
Interestingly, children seem to show reduced cortisol re-
sponses to stress factors during the first year of life (40,41),
Table 2. Multiple stepwise regression model
Regression coefficient Standard error
Gestational age 0.0246 0.0458
Birth weight 0.0011 0.0011
Gender 0.8982 0.9786
Mode of delivery 0.0947 1.0211
Stepwise regression of putative confounding factors on HPA axis activity.
The stepwise backward regression started with this full model, the criterion
for removing a variable was p  0.200. Adjusted R2 for full model: 0.0220.
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which seems to be a stress hyposensitive period. The absent
response to stress induction in our SGA population may
therefore reflect an accelerated HPA system maturation in
comparison to AGA infants accounting for inadequate time
for proper establishment of important developmental steps.
Growth-restricted preterm infants (32 wk of gestation)
seem to have a lower steroidogenic capacity than infants with
uninhibited fetal growth in response to ACTH stimulation
leading to an insufficient response to stress (42). This may be
related to enzyme deficiencies in the adrenal cortex (43).
However, ACTH stimulation cannot differentiate adrenal and
pituitary causes of a diminished response.
Stress hyposensitive periods at different stages of postnatal
development have been observed in animals as well (44).
Blunted cortisol responses to ACTH and acute stressors have
been observed in fetal sheep during chronic unfavorable in-
trauterine conditions (23,45). These observations are consis-
tent with changes on the molecular level reflected by alter-
ations in various hypothalamic receptor expression levels (11),
resulting in reduced HPA sensitivity. Considering these data,
intrauterine fetal stress because of undernutrition may lead to
a hyporeactivity of the HPA system to stressors in early life,
but seems to be modified by postnatal factors. If this notion
could be confirmed, HPA system plasticity during early life
would provide the chance to therapeutically influence the
system. Indeed, influencing the HPA system in the postnatal
period has been shown to be possible at least in animals (46).
It was suggested that mode of delivery may influence infant
HPA axis response in response to different stress levels for up
to 2 months of age (47) even though in a larger population this
finding was less clear (48). Saliva samples in our study were
obtained during the 4th day of life after stabilization of
birth-related fluctuations (49). According to a multiple step-
wise regression model, mode of delivery does not seem to
have an influence on the HPA axis response at least in our
collective. Furthermore, there is evidence from animal models
that females might be more sensitive to HPA axis program-
ming than males (50,51). However, we did not find a gender
difference in HPA axis reactivity in our study. Associations
between LBW and increased HPA axis activation have also
not been found to be different in adult men and women (52),
thereby confirming our results. It seems that gender-specific
cortisol reactivity in general depends on different levels of corti-
costeroid-binding globulin and sex steroids (53). We therefore
cannot exclude gender-specific hormonal influences that may
manifest during adolescence and adulthood in SGA infants.
Our data only provide a glimpse of HPA axis alteration in
the SGA neonate. We do not know whether these alterations
persist or how they change during life. Nevertheless, they
represent a prerequisite if intrauterine conditions per se are to
play a role in the etiology of adult diseases. Prospective
long-term investigations over years are required to prove this
hypothesis.
In conclusion, stress response in SGA infants seems to be
abnormal beginning as early as the neonatal period. However,
the characteristics of these abnormalities are changing con-
stantly during the course of life. Apparently, a hyporeactive
HPA axis system in early life is converted to a hyper-reactive
system, both being unfavorable. The exact mechanisms respon-
sible for these alterations are still elusive. The apparent plasticity
of the system provides hope that therapeutic reprogramming of
this system may be a realistic long-term objective.
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Scha¨ffer L, Burkhardt T, Mu¨ller-Vizentini D, Rauh M,
Tomaske M, Arlettaz Mieth R, Bauersfeld U, Beinder E. Cardiac
autonomic balance in small-for-gestational-age neonates. Am J
Physiol-Heart Circ Physiol 294: H884–H890, 2008. First published
December 7, 2007; doi:10.1152/ajpheart.00318.2007.—The cardiac
sympathetic nervous system is one putative key factor involved in the
intrauterine programming of adult cardiovascular disease. We there-
fore analyzed cardiac autonomic system activity in small for gesta-
tional age (SGA) neonates. Heart rate variability (HRV) from 24-h
ECG recordings were analyzed for time-domain and frequency-
domain parameters in 27 SGA neonates [median 261 (240–283) days
of gestation] compared with 27 appropriate for gestational age (AGA)
neonates [median 270 (239–293) days of gestation]. In addition,
salivary -amylase levels were analyzed during resting conditions and
in response to a pain-induced stress event in 18 SGA [median 266
(240–292) days of gestation] and 34 AGA [median 271 (240–294)
days of gestation] neonates. Overall HRV was not significantly
different in SGA neonates compared with AGA neonates (SD of all
valid NN intervals: P  0.14; triangular index: P  0.29), and the
sympathovagal balance [low frequency (LF)/high frequency (HF)]
was similar (P  0.62). Parameters mostly influenced by sympathetic
activity did not reveal significant differences: (SD of the average of
valid NN intervals: P  0.27; average of the hourly means of SDs of
all NN intervals: P  0.66, LF: P  0.83) as well as vagal tone-
influenced parameters were unaltered (average of the hourly square
root of the mean of the sum of the squares of differences between
adjacent NN intervals: P  0.59; proportion of pairs of adjacent NN
intervals differing by 50 ms: P  0.93; HF: P  0.82). Median
resting levels for -amylase were not significantly different in SGA
neonates (P  0.13), and a neonatal stress stimulus revealed similar
stress response patterns (P  0.29). HRV and salivary -amylase
levels as indicators of cardiac autonomic activity were not altered in
SGA neonates compared with AGA neonates. Thus, it appears that the
intrauterine activation of the sympathetic system in SGA fetuses does
not directly persist into postnatal life, and neonatal sympathovagal
balance appears to be preserved.
intrauterine programming; cardiovascular; amylase; heart rate vari-
ability; sympathovagal balance
THERE IS EVIDENCE that the development of adult cardiovascular
disease is initiated by unfavorable conditions during intrauter-
ine fetal life among genetic and environmental factor interac-
tions. This hypothesis of a fetal origin of adult diseases as
initially proposed by Barker et al. (7) has been reinforced by
epidemiological evidence of an inverse correlation between
birth weight and the risk for cardiovascular disease (17, 23,
30). Cardiovascular system regulation strongly depends on
sympathetic autonomic control. Sympathetic activity is be-
lieved to play an important role in the pathogenesis of essential
hypertension (15, 32, 33). During intrauterine life, malfunction
of the placenta is the major cause of undernutrition of the
developing fetus. The fetus survives by adaptation of metabolic
and cardiovascular systems mediated in part by the activation
of the sympathetic component of the autonomous system (38).
Thus, growth-restricted fetuses show increased levels of cat-
echolamines and glucocorticoids (16, 63). These adaptive
events occur at a developmental time when major regulating
systems of the organism are believed to still contain flexible set
points.
In low-birth-weight adults, surrogates for altered autonomic
cardiovascular control, such as an increased pulse rate (18, 45)
and, more specifically, altered blood pressure and heart period
variability (28, 60), have been described. Several animal mod-
els support the connection of an intrauterine adverse environ-
ment and alterations of the sympathoadrenergic system (26, 37,
48). Cardiovascular disease is associated with alterations in the
activation of the sympathoadrenergic system in the adult (12, 13).
Thus, the cardiac autonomic system balance may be permanently
altered according to the concept of fetal programming. During the
early postnatal period, one may speculate that temporary upregu-
lated systems normalize in response to a normal postnatal envi-
ronment, whereas permanently altered systems may become ap-
parent, making this time important for analysis.
Heart rate (HR) variability (HRV) is a well-established
noninvasive measure of cardiac autonomic control (22, 29).
The aim of this study was to analyze the cardiac autonomic
balance in small for gestational age (SGA) newborns by HRV
measurements. These electrophysiological findings were sup-
plemented by salivary -amylase measurements in response to
a stress stimulus. Salivary -amylase has been suggested to be
a surrogate for cardiovascular autonomic system balance cor-
relating well with HRV parameters (10, 41), thereby making
this parameter a promising indicator for cardiac autonomic
function.
METHODS
The study was approved by the Research Ethics Committee of the
University of Zurich and the Federal Ethics Commission of the canton
of Zurich. Written maternal consent was obtained. SGA was defined
as newborn weight below the fifth percentile of the gender-specific
newborn reference chart (58). Newborn weights of 10th and 90th
percentiles were required for appropriate for gestational age (AGA)
infants. Only healthy newborns delivered after 34 wk of gestation
(238 days postmenstruation) without intensive care requirements,
invasive procedures, or malformations were included. Since mothers
did not always give consent for both ECG and saliva sample collec-
tion, two separate populations had to be analyzed.
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HRV Measurements
A total of 54 children was recruited for 24-h Holter ECG measure-
ments containing 27 AGA and 27 SGA neonates. Gestational age at
delivery did not differ between groups (P  0.27). A summary of
newborn data is shown in Table 1. Three-channel Holter monitors
(Lifecard, Delmar Reynolds Medical, Hertford, UK) were placed
within the fourth postnatal day. Ectopic beats, noisy data, and artifacts
were manually identified and excluded from the HRV analysis. For
the calculation of HRV parameters, HRV Analysis software (version
9.3.0) from Nevrokard (www.nevrokard.eu) was applied.
According to the recommendations of the Task Force of the
European Society of Cardiology and North American Society of
Pacing and Electrophysiology (55) and the literature for neonatal
HRV measurements (5, 19, 47, 57), the following parameters were
analyzed.
Time-domain parameters. Time-domain parameters included the
following: 1) as an estimate of overall HRV, the SD of all valid NN
intervals (SDNN); 2) parameters mostly influenced by parasympa-
thetic activity, including the ratio of the number of all pairs of adjacent
NN intervals differing by 50 ms and the total number of RR
intervals (s-NN50), those differing by27 ms and the total number of
RR intervals (s-NN27), and those differing by 20 ms and the total
number of RR intervals (s-NN20) as well as the average of the hourly
square root of the mean of the sum of the squares of differences
between adjacent NN intervals (r-MSSD); and 3) parameters mostly
influenced by sympathetic activity, including the SD of the average of
valid NN intervals (SDANN) in 5-min segments in the recording and
the average of the hourly means of SDs of all NN intervals (SDNNi)
in 5-min segments. As a geometric index, the HRV triangular index,
defined by the total number of all NN intervals divided by the height
of the histogram of all NN intervals measured on a discrete scale with
bins of 7.8125 ms as an estimate of overall HRV, was calculated.
Frequency-domain parameters. Power spectral analysis was calcu-
lated by fast Fourier transformation (Hamming window) in four
frequency bands. To account for the neonatal physiology, frequency
bandwidths were adjusted according to the literature (19, 47): high
frequency (HF) was 0.24–1.04 Hz, representing parasympathetic
activity; low frequency (LF) was 0.04–0.24 Hz, representing both
sympathetic and parasympathetic activity; very LF (VLF) was 0.003–
0.04 Hz, mainly resulting from parasympathetic activity; and ultra LF
(ULF) was 0.000–0.003 Hz. Total power (in ms2) as well as the ratio
of LF to HF power (LF/HF), considered as a marker of sympathetic-
parasympathetic system balance, were analyzed.
-Amylase Measurements
Salivary -amylase levels of 36 AGA and 18 SGA infants were
analyzed. The infant’s age at delivery did not differ between groups
(P  0.8). A summary of newborn data is shown in Table 2.
To analyze sympathetic autonomic nervous system activity and
reactivity to stress, salivary -amylase samples were collected using
a routinely performed blood sampling (heel prick test) 72–96 h
postpartum as a pain-induced stress factor. This procedure has been
shown to be a significant stressor for the newborn (31, 34), and
salivary -amylase has been suggested as a measure of endogenous
adrenergic activity and changes in the autonomic nervous system in
general (11, 41) and specifically for cardiac autonomic balance (10,
21, 41). Saliva samples were collected from each infant 10 min before
and 5 and 20 min after stress induction. Collection time was based on
experiments revealing peak -amylase responses between 5 and 10
min after stress induction (41, 42). A cotton swab was placed in the
neonate’s mouth for a collection time of 5 min. Samples were placed
in saliva collection tubes (Salivette, Sarstedt, Nu¨mbrecht, Germany)
and stored frozen at 20°C until further analysis.
We used the amylase 4,6-ethylidene-p-nitrophenyl-,D-maltohep-
taoside method from Roche Diagnostics (Mannheim, Germany) for
the measurement of -amylase concentrations in saliva. The diluted
saliva samples (1  9) were analyzed with integra system 800. The
assays showed good performance characteristics (intra-assay coeffi-
cients of variation of1.0% and interassay coefficients of variation of
1.3% at concentrations of 79.9 and 198 U/l).
All statistical analyses were performed with STATA 9 statistics/
data analysis software (Stata, College Station, TX) according to
Altman’s and Matthews et al.’ recommendations (3, 36). Baseline
characteristics of SGA and AGA infants were compared using the
Mann-Whitney test and 2-test when appropriate. Since HRV param-
eters were not normally distributed as analyzed by the Shapiro-
Francia W-test, we compared SGA and AGA values using the Mann-
Whitney test. A stepwise multiple regression was conducted to ana-
lyze the impact of gender, gestational age, birth weight independent of
gestational age, and mode of delivery (spontaneous vaginal, operative
vaginal, and cesarean section). -Amylase data were log transformed
to normalize the distribution. The difference between -amylase
baseline levels and the time point of “5 min post” was calculated, and
differences revealed no deviation from a normal distribution (P 
0.49, Shapiro-Francia W-test). A paired Student’s t-test for unequal
samples was used to analyze alterations of log-transformed data
between study groups. The Mann-Whitney test was used for the
comparison of raw baseline -amylase levels. Stepwise multiple
regression was applied to test for putative influencing factors of
-amylase values such as gestational age, birth weight independent of
gestational age, mode of delivery (spontaneous vaginal, operative
vaginal, and cesarean section), and gender. The level of statistical
significance of all analyses was set at P  0.05.
RESULTS
Infant HRV
Median birth weight of SGA infants was 2,210 g, corre-
sponding to the 1.0st weight percentile, compared with 3,170 g,
corresponding to the 53rd percentile in AGA infants. The
median gestational age in both groups was comparable (261 vs.
270 days, P  0.27). A summary of study population charac-
teristics is shown in Table 1.
Time-domain parameters as an estimate of overall HRV,
such as SDNN and the triangular index, were not significantly
Table 1. Infant baseline characteristics for heart rate
variability measurements
AGA SGA P Value
Gestational age,
days 270 (239–293) 261 (240–283) 0.272
Birth weight, g 3,170 (2,000–3,830) 2,210 (1,340–2,760) 0.001
Weight percentile 54.8 (15.2–82.6) 1.0 (0.1–4.2) 0.001
Gender, male/female 7/20 12/15 0.154
Values are medians with ranges in parentheses; n  27 appropriate for
gestational age (AGA) neonates and 27 small for gestational age (SGA)
neonates.
Table 2. Infant basic characteristics
for -amylase measurements
AGA SGA P Value
Gestational age,
days 271 (240–294) 266 (240–292) 0.802
Birth weight, g 3,245 (2,100–3,740) 2,265 (1,470–2,870) 0.001
Weight percentile 48.2 (15.4–91.6) 1.6 (0.1–4.3) 0.001
Gender, male/female 16/18 6/12 0.341
Values are medians with ranges in parentheses; n  34 AGA neonates and
18 SGA neonates.
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different in SGA neonates compared with AGA neonates (P 
0.14 and P  0.29, respectively). The same was found for
parameters mostly influenced by sympathetic activity, such as
SDANN and SDNNi (P  0.34 and P  0.22, respectively).
Again, parameters mostly influenced by the vagal tone, such as
r-MSSD (P 0.99) as well as the proportion of pairs of adjacent
NN intervals differing by50,27, and20 ms (P 0.93, P
0.98, and P  0.91, respectively), revealed no significant differ-
ences between SGA and AGA neonates (Table 3). Analysis of all
frequency-domain parameters again revealed no significant dif-
ferences in SGA infants. Thus, HF, representing vagal activity
(P  0.82), LF, representing both sympathetic and vagal activity
(P  0.82), VLF (P  0.05), ULF (P  0.06), total power (P 
0.06), and LF/HF, representing sympathovagal balance (P 
0.62), were comparable in SGA and AGA infants (Table 3).
LF/HF similarly decreased with advancing gestational age in both
SGA and AGA infants (not shown). To test for a putative
influence of gestational age, gender, birth weight independent of
gestational age, and mode of delivery on HRV parameters, a
stepwise multiple regression was conducted, revealing an influ-
ence of gestational age (P 0.02) and gender (P 0.02) but not
of birth weight (P  0.95) or mode of delivery (P  0.34) for
LF/HF. For other time- and frequency-domain parameters, only
gestational age remained as an influencing factor, but not gender.
Infant -Amylase Levels
The median birth weight of SGA children was 2,265 g,
corresponding to the 1.6th weight percentile, compared with
3,425 g, corresponding to the 48.2th percentile in AGA chil-
dren. A summary of the characteristics of the study population
is shown in Table 2.
Median values for baseline -amylase levels were slightly
lower but not significantly different in SGA neonates compared
with AGA neonates (P 0.13; Fig. 1). After the application of
the stress stimulus, -amylase levels both slightly increased in
AGA and SGA neonates at the time point of “5 min post,” not
revealing statistically significant differences (P  0.3; Fig. 2).
To control for an influence of mode of delivery, gender,
gestational age, and birth weight independent of gestational
age, a stepwise multiple regression was performed, revealing
no significant influence (P  0.81, P  0.16, P  0.22, and
P  0.47, respectively).
DISCUSSION
We have shown that indicators of cardiac autonomic nervous
activity, such as HRV, are preserved in SGA neonates and that
the stress-induced -amylase response is not significantly al-
tered. Thus, our results suggest normal sympathoadrenergic
cardiovascular activity in SGA neonates.
Table 3. Time- and frequency-domain heart rate variability parameters in AGA and SGA infants
Median Minimum Maximum
P ValueAGA SGA AGA SGA AGA SGA
Heart rate, beats/min 131 130 112 107 154 149 0.29
Mean NN, ms 457.9 461.9 395.5 402.74 538.2 561.98 0.23
Triangular index 20 17 8 7 34 38 0.29
s-NN50, % 2.11 2.42 0.14 0.11 11.56 16.29 0.93
s-NN27, % 10.84 10.36 1.71 0.81 29.92 33.41 0.98
s-NN20, % 20.14 20.1 4.61 2.89 42.4 44.48 0.91
SDNN, ms 63.83 57.45 31.88 29.93 108.4 117.4 0.14
SDNNi, ms 37.33 35.39 18.79 18.63 61.38 72.85 0.22
r-MSSD, ms 19.26 20.52 10.54 9.16 36.27 45.64 0.99
SDANN, ms 48.03 43.23 24.11 21.59 85.18 92.07 0.34
HF, ms2 0.52 0.56 0.16 0.11 2.36 2.5 0.82
LF, ms2 2.09 2.1 0.59 0.35 5.73 9.6 0.82
VLF, ms2 4.77 3.34 0.98 0.88 10.11 13.05 0.052
ULF, ms2 6.91 4.34 1.26 1.56 26.13 22.12 0.06
Total power, ms2 13.75 11.08 2.99 3.85 42.8 47.04 0.06
LF/HF 3.75 3.53 1.69 1.92 9.05 8.59 0.62
s-NN50, ratio of the number of all pairs of adjacent NN intervals differing by 50 ms and the total number of RR intervals; s-NN27, ratio of the number of
all pairs of adjacent NN intervals differing by 27 ms and the total number of RR intervals; s-NN20, ratio of the number of all pairs of adjacent NN intervals
differing by 20 ms and the total number of RR intervals; SDNN, SD of all valid NN interval; SDNNi, average of the hourly means of SDs of all NN intervals;
r-MSSD, average of the hourly square root of the mean of the sum of the squares of differences between adjacent NN intervals; SDANN, SD of the average
of valid NN intervals; HF, high frequency; LF, low frequency; VLF, very LF; ULF, ultra LF.
Fig. 1. Salivary absolute levels (U/l) and medians for -amylase levels of
appropriate for gestational age (AGA; n  34) newborns and small for
gestational age (SGA; n 18) newborns before (baseline 1) and after (5 min
post  2; 20 min post  3) application of the stress stimulus.
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There is evidence from animal studies that an unfavorable
prenatal environment may alter the sympathetic autonomic
system balance, which seems to persist into postnatal life. As
such, prenatal stress has been shown to result in increased basal
and stimulated circulating catecholamine levels in adult rats
(26, 61), and compromised intrauterine blood flow did result in
a downregulation of epinephrine levels in sheep (1, 43, 51).
Conversely, chronic prenatal hypoxia has been shown to be
associated with sympathetic hyperinnervation (48, 49). Thus,
chronic intrauterine hypoxemia may suppress the adrenaline
synthetic capacity of the adrenal medulla (37, 43, 51), whereas
increased circulating norepinephrine concentrations seem to
derive from hyperinnervated sympathetic nerve terminals of
fetal vessels and tissues (37).
More specifically for the cardiovascular system, growth-
restricted newborn rats displayed significantly increased basal
cardiac sympathetic neuronal activity, as determined by
[3H]norepinephrine tracer and -methyltyrosine techniques
(51). In the same species, intrauterine exposure to exogenous
steroid levels produced persistent abnormalities of cardiac
noradrenergic innervation (8).
In the human, Flanagan et al. (18) found an inverse relation-
ship between adult resting pulse rate as an index related to
sympathetic activity and birth weight. Recently, markers of
impaired fetal growth were related to autonomic cardiovascular
control in adults involving modulation of both sympathetic and
parasympathetic function. Accordingly, blood pressure, HR, its
spectrum analysis, and baroreflex sensitivity in response to
psychological stress were found to be altered in low-birth-
weight women but not in men of an Australian prospective
cohort study (28, 59). Cardiac sympathetic nerve activity as
analyzed by cardiac preejection period and respiratory sinus
arrhythmia has been shown to be increased in adolescents born
growth restricted (24). In contrast, inconsistent results on
muscle vascular bed sympathetic nerve traffic have been re-
ported in low-birth-weight adults (9, 62).
HRV is a well-established noninvasive measure of cardiac
autonomic control that has been shown to be related to hyper-
tension (22, 29) and to predict future adverse cardiovascular
events in adults (2) and has been suggested for putative
prognostic use in children (54). While blood pressure as a
cardiovascular risk factor has been shown to be inversely
related to birth weight in adults, to our knowledge, a systematic
analysis of HRV parameters according to stardardized methods
(55) so far has not been performed in adults with low birth
weight. Alterations of HRV in adults, however, may not
necessarily represent a prenatal initiated event according to the
concept of fetal programming considering the close interaction
with other neuroendocrine systems such as the hypothalamus-
pituitary-adrenal (HPA) axis (8).
We did not find significant alterations of HRV parameters in
SGA neonates. These findings are consistent with the study of
Mehta et al. (39), who found no significant correlation between
various HRV parameters and birth weight in a population of 96
healthy newborns, although these authors may not have applied
appropriate frequency bands for the frequency-domain analy-
ses (19). In contrast, a small study by Spassov et al. (52)
described significantly decreased HRV parameters in term
SGA newborns during sleep at 2–10 days of postnatal life and
found significantly shorter NN intervals in SGA neonates,
which we did not observe despite similar SGA criteria. The
reason for these differing results are not clear but may be
explained by the small sample size and the different experi-
mental setting of that study. Indeed, it has been shown that HR
increases steeply after the 5th day of life with a maximum on
the 10th day, indicating distinct changes in cardiovascular
control (40). Therefore, it cannot be excluded that group
differences in postnatal age may have had an important influ-
ence on these results. Furthermore, single HRV parameters
could not be compared directly since long-term recordings for
time- and frequency-domain parameters were calculated in our
study as opposed to the short-term frequency-domain record-
ings in the study of Spassov et al. (52). Nevertheless, these
parameters seem to correlate well (39, 55). Galland et al. (20)
did not observe significant differences in NN intervals in SGA
infants, confirming our data. They found an increased resting
sympathetic tone using Poincare´ plot data analysis, however,
lying at the limits of significance (P  0.046) only after
controlling for HR at 1 and 3 mo of age and attributed these
findings to an immaturity of the autonomic nervous system.
Studies on functional central nervous system maturation in
SGA infants, however, have revealed conflicting results (4, 27,
44). There is evidence that HRV correlates with birth weight in
11- to 12-wk-old infants but not in younger infants (35). These
data suggest alterations of the cardiac autonomic nervous
system rather beyond the neonatal period. Therefore, one tends
to speculate that the cardiac autonomic nervous system rather
appears to be vulnerable during the postnatal development due
to conditions induced by putative permanently altered regula-
tory systems such as the HPA axis (46) and influence of
postnatal catchup growth (35). In support of this notion, it has
been shown in human fetuses that antenatal glucocorticoids
transiently lower short- and long-term fetal HRV (14). Alter-
natively, we cannot exclude that prenatal induced alterations
are too small to detect in the neonatal period and only become
apparent with increasing system maturation postnatally. Even
more, different methods thought to represent cardiac auto-
nomic activity may have different selectivity for sympathetic
system subunits (25), and different methods of stress induction
may produce different results (28).
Statistical analysis of our HRV parameters revealed three
frequency-domain parameters (total power, VLF, and ULF) to
be close to the level of statistical significance (Table 3). These
Fig. 2. Log-transformed salivary levels for -amylase during resting condi-
tions and after stress induction in AGA (n  34) and SGA (n  18) neonates.
Values are means  SE. Maximal -amylase response levels were not
significantly different between AGA and SGA neonates (P  0.3).
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parameters are closely connected as VLF and ULF components
correspond to up to 95% of the total power. Putative reductions
in total power as an estimate for autonomic nervous system
global activity and VLF might indicate a decrease in parasym-
pathetic modulation. The physiological correlate of VLF and
ULF, however, is not truly well established (55). Therefore,
although a false negative result cannot be completely excluded
for these parameters and a definitive conclusion may not be
drawn due to a relatively small sample size, all remaining
frequency- and time-domain parameters did not suggest statis-
tical significant differences of HRV in SGA neonates.
Direct comparison of these components with results from the
literature is rather difficult due to different experimental settings
and HRV calculations; however, Galland et al. (20) reported a
higher resting sympathetic tone analyzing 23 SGA infants using a
Poincare´ method for standard deviation of the beat intervals
(SDRR) and the standard deviation of the change between suc-
cessive beat intervals (SD	RR). However, only the SDRR/
SD	RR ratio reached the limit of statistical significance (P 
0.046), whereas the remaining parameters were not statistically
different. In the study of Spassov et al. (52), short-term HRV with
different frequency bands in 10 SGA infants were analyzed;
however, not all frequency parameters (LF) reached statistical
difference, and HR was significantly increased in SGA neo-
nates, potentially contributing to these findings. In contrast,
Galland et al.’s and our analysis did not observe increased HR
in SGA neonates.
There is evidence that autonomic cardiovascular control and
size at birth may be gender specific. Accordingly, adult low-
birth-weight women showed altered autonomic and baroreflex
parameters in response to psychological stressors, but not men
(28, 60). In our study, which conducted a stepwise multiple
regression, we found an influence of gender when analyzing
the entire data only for LF/HF but not for the remaining time
and frequency domains, making a gender effect at this time of
development rather questionable. However, gender was un-
equally distributed between groups, and subgroups were com-
paratively small; therefore, a definitive conclusion may not be
drawn. It is possible, however, that gender-specific hormonal
influences may manifest during adolescence and adulthood in
SGA infants.
To supplement our electrophysiological findings with a neu-
roendocrinological approach, we analyzed salivary -amylase
levels during resting conditions and after a stressful stimulus.
Acinar cells in the salivary glands are richly innervated by both
sympathetic and parasympathetic nerve fibers, influencing the
release of salivary -amylase by classic neurotransmitters (56).
Studies in humans and animals have suggested that the activa-
tion of the autonomic nervous system leads to a high activity
of salivary -amylase (6, 11, 50, 53). Furthermore, -amy-
lase levels have been found to be associated with cardio-
vascular physiology and are suggested to be a surrogate for
cardiovascular autonomic system balance (21). Bosch et al.
(10) found a significant negative correlation between the
parasympathetic-influenced HRV parameter r-MSSD and
-amylase levels during stress induction in adults. Further-
more, a positive correlation between -amylase levels and
LF/HF as a surrogate for sympathetic tone has been shown
(41), thereby making this parameter a promising indicator for
cardiac autonomic function.
To our knowledge, -amylase levels in SGA neonates have
not been studied before. Although studies on cardiovascular
autonomic physiology using -amylase measurements have
not been validated in neonates, several analyses from children
support the strong relationship between salivary -amylase and
sympathetic/parasympathetic nervous system activation in
younger individuals (21). The comparable -amylase levels
during resting conditions in AGA and SGA neonates in our
study and the absence of significant differences in response to
stress induction support the notion that the sympathetic auto-
nomic cardiovascular system seems not to be permanently
altered postnatally regarding the fetal origin hypothesis. The
sympathetic nervous system, however, is composed of multiple
function-specific subunits (25), and programming of sympa-
thetic nervous system function is believed to occur regionally
rather than on a global basis, suggesting that subdivisions of
the sympathetic nervous system may be influenced by different
sets of environmental variables (64). Therefore, we cannot
exclude that other subunits of the sympathetic nervous system
may be permanently altered in SGA neonates. Furthermore,
with regard to HRV techniques as well as -amylase measure-
ments, although in general use as research tools for the assess-
ment of cardiac autonomic activity, it is not entirely clear to
what degree they truly represent autonomic activity in
neonates.
In conclusion, HRV and salivary -amylase levels, as indi-
cators of cardiac autonomic activity, are not altered in SGA
neonates compared with AGA neonates. Thus, the neonatal
sympathovagal balance appears to be preserved in SGA
neonates.
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Antenatal Betamethasone Administration
Alters Stress Physiology in Healthy Neonates
Leonhard Schäffer, MD, Franziska Luzi, MD, Tilo Burkhardt, MD, Manfred Rauh, PhD,
and Ernst Beinder, MD
OBJECTIVE: To analyze hypothalamic-pituitary-adrenal
axis balance in healthy newborns after antenatal beta-
methasone treatment for lung maturation where delivery
could be prolonged until or near term.
METHODS: In a prospective observational study, salivary
cortisol and cortisone levels were measured at the fourth
day of life during resting conditions and in response to a
pain-induced stress event in 23 neonates with antenatal
exposure to a single course of betamethasone (212 mg)
and compared with 40 controls. The mean interval be-
tween betamethasone treatment and delivery was 6023
days.
RESULTS: On day 4 of life, neonates in the control group
exhibited a significant increase in cortisol and cortisone
from baseline levels after the stress induction (1.175–2.4
ng/mL for cortisol and 11.35–18.15 ng/mL for cortisone
[both P<.05]), whereas, in betamethasone-exposed neo-
nates, cortisol and cortisone stress response was not
significantly different from baseline levels (1.39–1.6
ng/mL for cortisone [P.76] and 14.8–17.1 ng/mL for
cortisol [P.69]). No influence of gestational age at
betamethasone administration (P.76) or gestational age
at delivery (P.71) on stress response patterns was ob-
served in a multiple stepwise regression.
CONCLUSION: A single course of antenatal betametha-
sone treatment induces a suppression of stress reactivity
in healthy newborns.
(Obstet Gynecol 2009;113:1082–8)
LEVEL OF EVIDENCE: II
Antenatal betamethasone administration in preg-nancies at risk for preterm delivery before 34
weeks of gestation is an established and effective
procedure to improve neonatal outcome by decreas-
ing neonatal mortality and infant morbidity.1 How-
ever, in different animal models, excessive prenatal
glucocorticoid administration reduces birth weight
and increases blood pressure and glucose levels and
alters the activity of the hypothalamic–pituitary–ad-
renal axis in adults.2 Although long-term studies in the
human after antenatal corticosteroid treatment have
not found adverse effects on general health and cardio-
vascular risk factors at 20 and 30 years, there was
evidence for insulin resistance in these individuals3,4 and
clinically apparent symptoms for cardiovascular dis-
ease may even appear at older ages. Moreover,
hypothalamic–pituitary–adrenal axis regulation has
not been assessed in these studies.
Therefore, concerns have been raised as to
whether prenatal treatment with corticosteroids may
entail long-term consequences for the health of these
individuals. The hypothalamic–pituitary–adrenal axis,
which is considered to be one of the major systems
involved in the fetal origin of adult diseases hypoth-
esis, has been shown to be vulnerable to excess
glucocorticoid exposure during its maturational
stage.5,6 Endogenous glucocorticoids are involved in
mediation of developmental steps of endocrine and
neurohumoral systems,7,8 and interference with this
fine neuroendocrine balance may alter the function of
these systems permanently.
Studies in premature neonates have shown that a
single course of antenatal betamethasone causes sup-
pression of stress reactivity because these neonates
failed to increase cortisol levels in response to a
stressor.9,10 Prematurity per se, prematurity-associated
morbidity, and the stressful environment of a neona-
tal intensive care unit (NICU) may have a consider-
able effect on neonatal stress regulation.11 Thus, allo-
cation of these effects to a specific event such as
From the Department of Obstetrics and Gynecology, University of Zu¨rich,
Zu¨rich, Switzerland; and the Department of Pediatrics, University of Erlangen,
Erlangen, Germany.
Corresponding author: Leonhard Schäffer, MD, Universitäts-Frauenklinik,
Frauenklinikstrasse 10, CH-8091 Zu¨rich, Switzerland; e-mail: leonhard.
schaeffer@usz.ch.
Financial Disclosure
The authors did not report any potential conflicts of interest.
© 2009 by The American College of Obstetricians and Gynecologists. Published
by Lippincott Williams & Wilkins.
ISSN: 0029-7844/09
1082 VOL. 113, NO. 5, MAY 2009 OBSTETRICS & GYNECOLOGY
antenatal betamethasone treatment appears difficult,
especially when considering that a pregnancy-associ-
ated complication usually precedes preterm delivery.
We therefore analyzed the hypothalamic–pitu-
itary–adrenal axis reactivity of healthy, late preterm
or term newborns who had received a single course of
antenatal betamethasone treatment for imminent pre-
term delivery before 34 weeks of gestation and in
whom preterm delivery was postponed for more than
a mean of 8 weeks. We hypothesized that stress
reactivity in these newborns is altered in comparison
with those in the control group.
MATERIALS AND METHODS
The study was approved by the Research Ethics
Committee of the University of Zurich and the federal
ethics commission of the canton of Zurich, and writ-
ten maternal consent was obtained from all partici-
pants in the study.
Only healthy newborns delivered after 34 weeks
of gestation (more than 238 days) were included in the
study. Forty-four neonates who had received antena-
tal betamethasone administration (212 mg within 24
hours) for imminent preterm delivery were delivered
after 34 weeks of gestation during the study period
(September 2006 to April 2007). In 21 cases, either
parents refused to participate in the study (16 cases) or
saliva collection was inadequate (five cases). Saliva
samples of 23 neonates (study group) could be in-
cluded in our analysis. The experience from a previ-
ous study allowed us to presume that, with regard to
the variability of cortisol levels, approximately half of
the number of controls provides a statistically ade-
quate study group sample size. Accordingly, 40
healthy neonates, whose cases have been published
previously,12 served as controls (control group). These
neonates were born in the same institution between
April and September 2005, and methods for saliva
collection and laboratory analysis were identical.
Neonatal weight between the 10th and 90th percen-
tiles was required for both study groups. Newborns
were excluded from analysis when intensive care
treatment or invasive procedures had been necessary,
when malformations were present, or when insuffi-
cient amounts of saliva were collected. Furthermore,
maternal substance abuse (nicotine, alcohol) during
pregnancy was an exclusion criterion. No signs of
clinically apparent infections were present in either
group. Two pregnancies in the study group were
complicated by preterm premature rupture of mem-
branes and four pregnancies by vaginal bleeding,
leading to betamethasone treatment for imminent
preterm delivery. The remaining cases were treated
for preterm contraction and cervical ripening. Ultra-
sonographic measurements of fetal crown-rump
length and biparietal diameter during the first trimes-
ter served as parameters for accurate determination of
gestational age.
Stress reactivity was tested in newborns using a
standardized procedure with an automated heel lance
(heel-prick test) as a stress event. This test is a
routinely applied screening test in which blood is
sampled and analyzed for metabolic disorders (Guth-
rie test). Saliva samples were collected from each
neonate 10 minutes before and 20 minutes after the
stress event 72–96 hours postpartum between 8 AM
and 1 PM and analyzed for salivary cortisol and
cortisone levels. Baseline levels were obtained in an
undisturbed environment. Collection time was based
on experiments revealing peak cortisol responses
between 20 and 30 minutes postmanipulation.13 In
detail, a cotton swab was placed in the neonate’s
mouth for a collection time of 5 minutes. Salivary
cortisol reflects the unbound, active fraction of corti-
sol and is highly correlated with plasma cortisol
levels.14,15 Samples were placed in saliva-collection
tubes (Salivette, Sarstedt, Nu¨mbrecht, Germany), im-
mediately frozen, and stored at -20°C until further
analysis.
Saliva cortisol and cortisone were determined
simultaneously by liquid chromatography tandem
mass spectrometry, with atmospheric pressure chem-
ical ionization in the positive ion mode, according to
a modified method of Rauh et al16 using 100 microli-
ters of the samples and calibrators, as previously
described in detail.12
We applied STATA 9 statistics/data analysis soft-
ware (Stata Corporation, College Station, TX) for
statistical analysis according to Altman’s recommenda-
tions for repeated measurements that rise from the same
individuals studied under different circumstances.17
Baseline characteristics were compared using the
Mann-Whitney test and 2 test when appropriate.
Because basal levels of cortisol vary considerably in
individual newborns and children,13 absolute values
and median relative alterations are presented. Be-
cause cortisol and cortisone values were not distrib-
uted normally as analyzed by the Shapiro-Francia W’
test, we analyzed the difference between cortisol and
cortisone baseline levels and time point “20 minutes
post” using the Wilcoxon signed rank test. Mann-
Whitney test was used for comparison of baseline
cortisol and cortisone levels. To account for within-
subject variations, a two-way analysis of variance for
repeated measurements was conducted. A stepwise
multiple regression was applied to test for putative
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influencing factors on cortisol alterations such as
gestational age at betamethasone administration, ges-
tational age at delivery, neonatal weight, and sex. The
resulting regression coefficient indicated the predicted
increase in the dependent variable for each unit
increase in the explanatory variable. To validate our
statistical analyses, a power calculation was con-
ducted for the given sample size (n23), assuming
the mean increase in cortisol levels of neonates in
the control group as relevant. Finally, cortisol and
cortisone levels in the study group were tested for
correlation using the Spearman rank correlation
test. The level of statistical significance of all anal-
yses was set at P.05.
RESULTS
The mean interval between betamethasone adminis-
tration and birth was 60 (23) days. Gestational age,
birth weight, weight percentile, and head circumfer-
ence at birth did not differ significantly between the
study group and control group. Betamethasone was
administered at a mean gestational age of 29.4 (2.6)
weeks. A summary of the characteristics of the study
population is given in Table 1.
The median baseline levels for cortisol and corti-
sone did not differ significantly between neonates in the
study group and those in the control group (1.39 ng/mL
[range 0.09–9.82] compared with 1.175 ng/mL [range
0.09–15.7] for cortisol, P.42; 14.8 ng/mL [range 2.6–
36] compared with 11.35 ng/mL [range 5.83–44.3] for
cortisone, P.34, respectively). Individual baseline
and stimulated cortisol and cortisone levels are indi-
cated in Figure 1.
In neonates in the control group, analysis of the
physiological stress response revealed a significant
increase in cortisol and cortisone levels in response to
the heelstick, as was expected (2.4 ng/mL [range
0.3–12.2], 18.15 ng/mL [range 2.8–43.1], respec-
tively, P.05, Fig. 1). In contrast, neonates in the
study group displayed a noticeably blunted stress
response—cortisol and cortisone release was not sig-
nificantly different from baseline levels (1.6 ng/mL
[range 0.2–11.3], P.76 and 17.1 ng/mL [range
7–32.9], P.69, respectively, Fig. 1). A two-way anal-
ysis of variance again revealed that there was no
significant alteration of cortisol after the stress stimu-
lus in the study group (P.65) as opposed to control
group (P.003). A one-sample t-test power calcula-
tion validated the absent cortisol response in neonates
in the study group with a power of 99% at a signifi-
cance level of 0.05. For better visualization of alter-
ations before and after stress stimulus medians of
relative alterations for cortisol and cortisone, see
Figure 2.
To test whether the reduced cortisol response in
the neonates in the study group could be influenced
by gestational age at steroid administration, a stepwise
multiple regression model was applied, revealing no
significant association (P.76). Subsequently, neona-
tal weight, sex, and gestational age at delivery were
tested, and none of them had a significant influence
on cortisol response levels in the study group (P.71,
P.74, P.71, respectively) (Table 2). Finally, we
tested whether the decreased cortisol response in the
study group was mediated by an increased conversion
of cortisol to cortisone. Cortisol and cortisone levels
were strongly correlated in the study group, thus
excluding this possibility (P.76).
DISCUSSION
Our results indicate that a single course of betametha-
sone administration in pregnancies at risk for preterm
delivery entails alterations in hypothalamic–pitu-
itary–adrenal axis responsiveness that persist into
Table 1. Maternal and Neonatal Baseline Characteristics
Control (n40) Study Group (n23) P
Gestational age (d) 273 (240–294) 266 (242–284) .201
Birth weight (g) 3,288 (2,100–3,780) 2,950 (2,220–3,930) .269
Weight percentile 52 (17.6–91.6) 39 (11.9–87.3) .617
Male/female 18/22 13/10 .907
Head circumference 34.5 (32.5–36) 34 (32–37) .583
5-min Apgar score 9 (8–10) 9 (8–9) .517
Maternal hospital stay (d) 0 (0–11) 8 (0–85) .001
Maternal age (y) 30 (18–39) 29 (23–37) .496
Parity 2 (1–4) 1 (1–3) .040
Maternal pregestational BMI 23 (16–38.6) 21.3 (18.3–36.9) .100
Maternal BMI at delivery 27.7 (23.7–41.9) 26.2 (21.8–39) .153
BMI, body mass index.
Data are median (range) unless otherwise specified.
1084 Scha¨ffer et al Antenatal Betamethasone in Healthy Neonates OBSTETRICS & GYNECOLOGY
postnatal life, even if delivery can be avoided until or
near term.
Previous studies in premature neonates (28–30
weeks of gestation) have suggested that antenatal
betamethasone treatment persistently suppresses cor-
tisol responsiveness to a stressor for at least 4–6
weeks after birth.10 Owing to the setting of that study,
however, prematurity itself as well as the effect of
stressful postnatal intensive care unit handling may
have had considerable influence on these results.
Unfortunately, owing to the lack of an appropriate
control group of equal gestational age, these neonates
were compared with a control cohort delivered at
33–34 weeks of gestation, significantly later than the
study group. Thus, these cofactors could not be
controlled for. In a small study population (n9),
however, the same group of investigators analyzed
the hypothalamic–pituitary–adrenal response in a
NICU situation in preterm neonates born at 33–34
weeks of gestation, again revealing a decrease in
cortisol response after antenatal betamethasone
administration.9
Baseline cortisol levels after antenatal corticoste-
roid treatment have been shown to be suppressed
transiently for 2–7 days in preterm neonates,18,19 and
cortisol response levels to a pharmacologic challenge
were lower in preterm very low birth weight neonates
after a single course of antenatal betamethasone ad-
ministration 7 days postpartum. Curiously, this could
not be shown for multiple doses of betamethasone
administration. However, at 14 days postpartum,
these differences no longer could be observed, thus
indicating a transient effect.11 In fact, there is
evidence, that premature newborns have an imma-
ture hypothalamic–pituitary–adrenal axis so that
the hypothalamus may fail to recognize the stimu-
latory signal or adrenal steroidogenesis may be
ineffective yet.20–22
The present study is the first to analyze stress
physiology in healthy term or near-term neonates
after a single course of betamethasone administration
at a much earlier time in pregnancy. Consequently,
these neonates did not experience the potentially
stressful environment of a NICU, and prematurity-
Fig. 1. Salivary absolute levels for cortisol (A, B) and cortisone (C, D), including individual courses of control (n40) and
study group (n23) newborns before (baseline) and after (after stress stimulus) application of the stress stimulus. The line
indicates median levels.
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associated effects with related morbidity can be ex-
cluded. Likewise, putative influencing factors such as
smoking during pregnancy or intrauterine compro-
mise of the fetus had been excluded explicitly, in
contrast to studies in preterm neonates. Furthermore,
the mean interval between betamethasone adminis-
tration and hypothalamic–pituitary–adrenal axis anal-
ysis was more than 8 weeks, thereby excluding tran-
sient short-term effects.
Animal models in different species collectively
show that corticosteroid application in pregnancy
permanently affects hypothalamic–pituitary–adrenal
axis function and behavior in offspring.5 Unlike en-
dogenous glucocorticoids, synthetic glucocorticoids
predominantly bind to glucocorticoid receptors be-
cause the mineralocorticoid receptors have low affinity
to exogenous glucocorticoids.23 Thus, the glucocorticoid
receptor is likely to be affected predominantly. In the
rodent, a single course of antenatal betamethasone
induced a decrease in hippocampal glucocorticoid
receptor expression.24 Interestingly, disruption of the
glucocorticoid receptor gene in the central nervous
system in knock-out mice results in an impaired
behavioral response to stress.25 Constant receptor
alterations have been described at the level of the
limbic system in the hippocampus (involved in nega-
tive feedback), the amygdala (involved in activation),
and the paraventricular nucleus.26–30
In guinea pigs, a single equivalent dose of glu-
cocorticoids used in pregnant women caused signifi-
cantly lower hippocampal glucocorticoid receptor
mRNA levels in females, accompanied by an attenu-
ated stress response. In contrast, glucocorticoid recep-
tor mRNA levels were elevated in males that showed
elevated basal but not stress-induced cortisol levels.31
Repeated doses of glucocorticoids induced sex-spe-
cific differential effects on mineralocorticoid receptor
mRNA and glucocorticoid receptor mRNA levels in
different regions.32 Animal models have shown fur-
ther that females might be more sensitive to hypo-
thalamic–pituitary–adrenal axis programming than
males.33,34 We did not observe a sex-dependent dif-
ference in hypothalamic–pituitary–adrenal axis reac-
tivity in our study, just as a study in adults analyzing
postmenopausal women.35 Sex-specific cortisol reac-
tivity in general depends on different levels of corti-
costeroid-binding globulin and sex steroids.36 We
therefore cannot exclude sex-specific hormonal influ-
ences that may manifest at a later time during adoles-
cence and adulthood in these neonates.
The mechanisms underlying hypothalamic–pitu-
itary–adrenal axis balance thus are complex and
depend on timing and dose of glucocorticoid expo-
sure.29 The variability in neurodevelomental profiles
of different species further adds to the difficulty in
drawing conclusions for the human situation.
Limited data on prenatal glucocorticoid treat-
ment in nonhuman primates indicate structural and
morphological alterations in the area of the hip-
Table 2. Multiple Stepwise Regression Model
Regression
Coefficient
Standard
Error
Gestational age at delivery 0.0721 0.1343
Newborn weight 0.0013 0.0032
Sex 0.8209 1.9243
Gestational age at time of
steroid administration 0.0158 0.0496
Stepwise regression of putative confounding factors on hypo-
thalamic–pituitary–adrenal axis activity. The stepwise back-
ward regression started with this full model; the criterion
for removing a variable was P.200. Adjusted R2 for full
model 0.1919.
Control Study group
0.0
A
Control Study groupB
Fig. 2. Median relative salivary level alterations for cortisol
after stimulus (1.9 [range 0.02–55.5] compared with 0.72
[range 0.13–50]) (A) and cortisone after stimulus (1.2
[range 0.39–4.7] compared with 0.95 [range 0.63–4.1]) for
control and study groups respectively (B).
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pocampus and an altered set point for basal and
stress-induced cortisol levels at the age of 9 months.37
Furthermore, alterations in cytoskeletal proteins and
presynaptic terminals involved in neuroplasticity
were observed after equivalent doses of betametha-
sone in the baboon.38
In the human, betamethasone-induced alterations
in hippocampal mineralocorticoid receptor mRNA
expression levels could not be observed in preterm
neonates who died 4 days after delivery (n9); how-
ever, glucocorticoid receptor mRNA alterations that
may be of major relevance could not be analyzed
reliably, which makes it difficult to draw conclu-
sions.39 Different gestational ages and variabilities in
glucocorticoid exposure as well as other factors, such
as stress due to intensive care settings, further add to
the difficulty of interpreting these data.
The strength of the present study is that study
groups are largely free from maternal- and neonatal-
derived interfering factors such as prematurity-associ-
ated interventions and morbidities. Furthermore, the
long interval between betamethasone administration
and delivery (mean 60 days) does exclude transient
short-term effects of betamethasone on the hypo-
thalamic–pituitary–adrenal axis. Nevertheless, beta-
methasone administration implies the presence of a
risk for preterm delivery, and we cannot exclude the
possibility that these risk factors, such as preterm
contractions and their treatment, bleeding, undetect-
able infections, and event- or hospitalization-associ-
ated stress situations for the mother, add to the
alteration of hypothalamic–pituitary–adrenal axis re-
sponsiveness. Indeed, median maternal hospital stay
during pregnancy was 8 days. Furthermore, whether
our observed effects transform into long-term conse-
quences has to be established by follow-up studies.
We would like to point out that antenatal glu-
cocorticoid administration in pregnancies at risk for
preterm delivery has established benefits in reducing
neonatal mortality and morbidity,1 and it is not clear
to what extend our observed alterations associated
with this procedure really are relevant determinants
for diseases in later life. However, if a permanent
alteration of the hypothalamic–pituitary–adrenal axis
occurs in the human fetus after the application of a
single course of betamethasone treatment, hypotha-
lamic–pituitary–adrenal axis function would be ex-
pected to be modified already in the neonate. This
precondition for a persistent reprogramming of the
hypothalamic–pituitary–adrenal axis has been dem-
onstrated in our study. Long-term follow-up studies
analyzing hypothalamic–pituitary–adrenal axis reac-
tivity are not yet available. In a 30-year follow-up
study of Dalziel et al,3 basal plasma cortisol levels
were unaltered after a single course of maternal
betamethasone administration; stress reactivity, how-
ever, was not analyzed, and clear indicators for the
presence of insulin resistance were present in these
individuals.
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ABSTRACT: Beneficial effects of antenatal glucocorticoid treat-
ment in pregnancies at risk for preterm delivery may entail long-term
consequences for the establishment of sympathoadrenergic system
balance. We analyzed the cardiac autonomic system activity in
neonates with a single course of antenatal betamethasone (2  12
mg) treatment by calculating heart rate variability (HRV) time-
domain parameters from 24 h ECG recordings and short-term fre-
quency-domain parameters during infant active and resting states. In
addition, resting and challenged salivary -amylase levels were
measured in 23 betamethasone-exposed neonates and compared with
controls. Indicators for overall HRV (SDNN: p  0.258; triangular
index: p  0.179) and sympathovagal balance [low- to high-
frequency power (LF/HF): p  0.82 (resting state)] were not signif-
icantly different in neonates of the betamethasone treatment group.
Parameters mostly influenced by sympathetic activity [SD of the
average of valid NN intervals (SDANN): p  0.184 and SDs of all
NN intervals (SDNNi): p 0.784] and vagal tone [RMSSD: p 1.0;
NN50: p  0.852; HF: p  0.785 (resting state)] were unaltered.
Resting -amylase levels were not significantly different in the
betamethasone treatment group (p  0.304); however, -amylase
release after a neonatal challenge was slightly reduced (p  0.045).
Thus, cardiac autonomic balance seems to be preserved in neonates
exposed to a single course of antenatal betamethasone treatment.
(Pediatr Res 68: 286–291, 2010)
Antenatal glucocorticoid treatment for lung maturation inpregnancies at risk for preterm delivery is an established
method to reduce neonatal mortality and morbidity (1). How-
ever, there is accumulating evidence that glucocorticoids may
alter maturational development and homeostasis of fetal reg-
ulatory systems. Repeated antenatal glucocorticoid exposure
results in reduced birth weight, increased blood pressure, and
glucose levels in adult offspring in different animal models (2).
The cardiac autonomic system has been shown to be sen-
sitive toward antenatal glucocorticoids. Accordingly, fetal
heart rate (FHR) variation is altered at least transiently in
human fetuses after antenatal glucocorticoids (3,4), and infant
heart rate answer to a stress event is significantly increased
(5). Putative mechanisms include an altered cardioregulatory
innervation and signaling that seem to happen at central levels
and at the level of the cardiomyocyte according to rodent
models (6,7).
Cardiovascular system regulation strongly depends on sym-
pathetic autonomic control that is believed to play an impor-
tant role in the pathogenesis of cardiovascular disease in the
adult (8,9). Long-term observations in adolescents and young
adults with antenatal exposure to glucocorticoids have rather
focused on classic signs of disease manifestation such as
blood pressure (10,11). However, risk factors for cardiovas-
cular or metabolic disease may transform into apparent clin-
ical manifestation at a more advanced age when stability of
these systems can be less compensated by the organism.
Therefore, we focused on putative predictive methods char-
acterizing sympathoadrenergic cardiac balance. Heart rate
variability (HRV) is a well-established noninvasive measure
of cardiac autonomic control (12,13) that is regulated by a
complex interplay of sympathetic and parasympathetic
branches of the autonomic nervous system. The aim of this
study was to analyze the cardiac autonomic balance of healthy
newborns at or near term who had received a single course of
antenatal betamethasone treatment for imminent preterm de-
livery before 34 wk of gestation and in whom delivery was
delayed for a median of more than 7 wk. Electrophysiological
HRV data were supplemented by functional salivary -amy-
lase measurements in response to a stress stimulus. Salivary
-amylase has been suggested to be a surrogate for cardio-
vascular autonomic system balance correlating well with HRV
parameters (14,15).
METHODS
The study was approved by the Research Ethics Committee of the Uni-
versity of Zurich and conforms with the Declaration of Helsinki. Written
parental consent was obtained from all participants.1
Healthy infants born after 34 wk of gestation (238 d postmenstruation)
were included in the study. Exclusion criteria were infant intensive care
treatment or invasive procedures, malformations, maternal substance abuse
(nicotine and alcohol) during pregnancy, or insufficient amounts of saliva
collected. No signs of clinical apparent infections were present in both groups.
Sonographic measurements of fetal crown-rump length and biparietal diam-
eter during the first trimester served as parameters for accurate determination
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of gestational age. Because mothers did not always give consent for both ECG
and saliva sample collection, the populations were analyzed separately.
HRV measurements. A cohort of 23 infants with antenatal betamethasone
treatment was recruited for 24 h Holter ECG measurements (treatment group).
The control group of 23 infants without antenatal betamethasone exposure is
part of a cohort previously published (16). A summary of infant and maternal
characteristics is shown in Table 1. Three-channel Holter monitors (Lifecard
CF; Delmar Reynolds Medical, Hertford, United Kingdom) were placed
within the third to fourth postnatal day. Ectopic beats, noisy data, and artifacts
were manually identified and excluded from the HRV analysis. For calcula-
tion of HRV parameters, the HRV Analysis Software, version 9.3.0 from
Nevrokard (www.nevrokard.eu) was applied.
To account for long-term and for short-term HRV variations, the total
monitoring period of 24 h was analyzed for time-domain parameter calcula-
tion, and selected 5-min segments were analyzed for frequency-domain
parameter calculation to account for different states of activation. According
to the recommendations of the Task Force of the European Society of
Cardiology and North American Society of Pacing and Electrophysiology
(17) and the literature for neonatal HRV measurements (18–21), the follow-
ing parameters were analyzed.
Time-domain parameters [calculated from the total monitoring period
(24 h)]. 1) Parameters as estimate of overall HRV: the SD of all valid NN
intervals (SDNN), 2) parameters mostly influenced by parasympathetic ac-
tivity: The ratio of the number of all pairs of adjacent NN intervals differing
by 50 ms and the total number of RR intervals (%) (s-NN50), 27 ms
(s-NN27) and 20 ms (s-NN20), the average of the hourly square root of the
mean of the sum of the squares of differences between adjacent NN intervals
(RMSSD), 3) parameters mostly influenced by sympathetic activity: The SD
of the average of valid NN intervals (SDANN) in 5-min segments in the
recording, the average of the hourly means of SDs of all NN intervals
(SDNNi) in 5-min segments. As geometric index, the HRV triangular index,
defined by the total number of all NN intervals divided by the height of the
histogram of all NN intervals measured on a discrete scale with bins of 7.8125
ms as estimate of overall HRV was calculated.
Frequency-domain parameters (5 min segments). Power spectral analysis
was calculated by fast Fourier transformation (Hamming window) in three main
spectral components. To account for the neonatal physiology, frequency band-
widths were adjusted according to the literature (18,19): high frequency (HF):
0.24 to 1.04 Hz, representing parasympathetic activity; low frequency (LF):
0.04 to 0.24 Hz, representing both, sympathetic and parasympathetic activity;
and very low frequency (VLF): 0.003 to 0.04 Hz with a less-defined physi-
ologic role. Total power (ms2) and the ratio of LF/HF considered as a marker
of sympathetic-parasympathetic system balance were analyzed. Absolute
values (ms2) and normalized units (n.u.) that represent the relative value of
each power component in proportion to the total power minus the VLF
component were calculated. The presentation of LF and HF in n.u. empha-
sized the controlled and balanced behavior of the two branches of the
autonomic system (17).
-amylase measurements. Salivary -amylase levels were analyzed from
a cohort of 23 infants with antenatal betamethasone treatment and from a
cohort of 40 controls that have been published previously (22). A summary of
infant and maternal characteristics is shown in Table 1.
Samples were collected using a routinely performed blood sampling (heel
prick test) 72 to 96 h postpartum as pain-induced stress factor. This procedure
has been shown to be a significant stressor for the newborn (23,24), and
salivary -amylase has been suggested as a measure of endogenous adrener-
gic activity and changes in the autonomic nervous system in general (15,25)
and specifically for cardiac autonomic balance (14,15,26). Saliva samples
were collected from each infant 10 min before and 5 and 20 min after stress
induction. Collection time was based on experiments revealing peak -amy-
lase responses between 5 and 10 min poststress induction (15,27). A cotton
swab was placed in the neonates’ mouth for a collection time of 5 min.
Samples were placed in saliva collection tubes (Salivette; Sarstedt, Nu¨mbre-
cht, Germany) and stored frozen at 20°C until further analysis.
The amylase 4,6-ethylidene-p-nitrophenyl-,D-maltoheptaoside (EPS)
method from Roche Diagnostics, Mannheim, Germany, was applied for the
measurement of the -amylase concentration in saliva. The diluted saliva
samples (1 9) were analyzed on the Integra system 800. The assays showed
good performance characteristics [intraassay coefficient of variation (CVs) 
1.0% and interassay CVs  1.3% at concentrations of 79.9 and 198 U/L].
Statistical analysis. All statistical analyses were performed with STATA
10 Statistics/Data Analysis Software (Stata Corporation, College Station,
TX). Baseline characteristics of treatment and control infants were compared
using the Mann-Whitney test and 2 test when appropriate. Because HRV
parameters were not normally distributed as analyzed by the Shapiro-Francia
W’ test, we compared groups using the Mann-Whitney test. -Amylase data
were log transformed. The Mann-Whitney test was used for comparison of
baseline -amylase levels. Alterations of log-transformed data between base-
line and poststimulation levels were analyzed by the Wilcoxon signed-rank
test. To account for within-subject variation, a two-way ANOVA for repeated
measurements was conducted. A stepwise multiple regression was applied to
analyze the impact of gestational age at steroid administration, birth weight
percentile, and gestational age at delivery as putative influencing factors on
-amylase values. The level of statistical significance of all analyses was set
at p  0.05.
RESULTS
Infant HRV. Betamethasone treatment was conducted at a
median gestational age of 219 (178–238) d (corresponding to
312⁄7 wk of gestation), and the median interval between treat-
ment and delivery was 51 (25 to 108) d. Median birth weight
and weight percentile were comparable between treatment and
control groups (3040 g and 50th percentile versus 3260 g and
54.8th percentile). Infants of the treatment group were deliv-
ered2 wk earlier [260 d (371⁄7 wk of gestation) versus 275 d
(39 2/7 wk of gestation], just not reaching statistical signifi-
cance (p  0.0504). Infant head circumference and 5-min
Apgar levels were similar (p  0.740 and p  0.757, respec-
tively). A summary of the characteristics of the study popu-
lation is depicted in Table 1.
For the long-term HRV analysis, the time-domain parame-
ters SDNN and the triangular index representing estimates for
Table 1. Neonatal and maternal baseline characteristics for HRV measurements and salivary -amylase measurements
HRV measurements -Amylase measurements
Control
(n  23)
Treatment group
(n  23) p
Control
(n  40)
Treatment group
(n  23) p
Gestational age (d) 275 (239–293) 260 (245–289) 0.0504 273 (240–294) 266 (242–284) 0.201
Birth weight (g) 3260 (2150–3830) 3040 (2170–3750) 0.2104 3288 (2100–3780) 2950 (2220–3930) 0.269
Weight percentile 54.8 (15.4–82.6) 50.0 (15.2–88.9) 0.7334 52 (17.6–91.6) 39 (11.9–87.3) 0.617
Male/female 3/20 12/11 0.011 18/22 13/10 0.907
Head circumference 34 (31–37.5) 34.5 (31–36.5) 0.7402 34.5 (32.5–36) 34 (32–37) 0.583
5-Min APGAR 9 (8–10) 9 (8–10) 0.7571 9 (8–10) 9 (8–9) 0.517
Maternal age (y) 30 (16–41) 30 (21–41) 0.8342 30 (18–39) 29 (23–37) 0.496
Parity 1 (1–3) 1 (1–4) 0.6088 2 (1–4) 1 (1–3) 0.040
Maternal pregestational BMI 21.1 (18.9–31.2) 19.7 (17.7–36.9) 0.1142 23 (16–38.6) 21.3 (18.3–36.9) 0.100
Maternal BMI at delivery 26.0 (22.2–32.8) 24.9 (21.8–39.6) 0.5774 27.7 (23.7–41.9) 26.2 (21.8–39) 0.153
Gestational age at steroid administration (d) 219 (178–238) 204 (173–235)
Data are median (range) unless otherwise specified.
BMI, body mass index.
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overall HRV were not significantly different in the treatment
group compared with the controls (p  0.258 and p  0.179,
respectively). Similarly, parameters, mostly influenced by
sympathetic activity, such as SDANN and SDNNi were sim-
ilar (p  0.184 and p  0.784). No significant differences
were also found for estimates of vagal tone as RMSSD (p 
1.0) and for the proportion of pairs of adjacent NN intervals
differing by 50, 27, and 20 ms (p  0.852, p  0.684,
and p  0.818; Table 2). Short-term HRV analysis during
active and resting states calculating frequency-domain param-
eters confirmed these results. Although there was a significant
difference between active and resting states within each group
as expected (data not shown), comparison of parameters be-
tween similar states of activation were not significantly dif-
ferent when calculating absolute and normalized values. Ac-
cordingly, HF, representing vagal activity; LF, representing
both sympathetic and vagal activity; VLF, representing total
power; and LF/HF, representing sympathovagal balance, all
were not significantly different from control infants (Table 3).
The likelihood to miss a putative significant difference by our
sample size is very low [5.2% (  0.8,   0.05) for
RMSSD and LF/HF (n.u.) resting state].
Infant -amylase levels. Betamethasone treatment was
conducted at a median gestational age of 201 (173–235) d, and
the median interval to delivery was 55 (16–102) d. Median
birth weight and weight percentile were comparable in both
groups (p  0.269 and p  0.617, respectively). Gestational
age at delivery was 266 (242–284) d in the treatment group
and 273 (240–294) d in the control group (p  0.201). Head
circumference and 5-min Apgar scores were similar (p 
0.583 and p  0.517, respectively). A summary of the char-
acteristics of the study population is shown in Table 1.
Median baseline levels for -amylase were slightly higher
but not significantly different in the treatment group when
compared with controls (p  0.3040, Fig. 1). -Amylase
levels in control infants increased marginally, just reaching the
level of statistical significance (p  0.045) at the time point
5-min poststimulation, whereas in infants with betamethasone
treatment, no significant alteration of -amylase release was
observed (p  0.408). A two-way ANOVA confirmed that
there was a significant alteration of -amylase in the control
(p  0.0266) but not in the study group (p  0.183) after the
stress stimulus. No significant influence of gestational age at
steroid administration (p  0.82), newborn weight (p 
0.079), and gestational age at delivery (p  0.46) was ob-
served applying a multiple stepwise regression model.
Figure 1. Individual log-transformed salivary levels and medians for -amy-
lase in control (n  40) and study group (n  23) newborns before (baseline)
and after (5 and 20 min after) application of the stress stimulus. (left  control;
right  study group). Horizontal line indicates median levels. *p  0.05.
Table 2. Long-term time-domain HRV parameters in control and treated (betamethasone) group
Median Minimum Maximum
pControl Treated Control Treated Control Treated
HR (bpm) 126 132 112 112 152 137 0.4218
Mean NN (ms) 478.2 455.9 395.5 438.5 538.2 534.4 0.3976
Triangular index 20 17 8 10 34 28 0.1792
s-NN50 (%) 2.46 2.13 .14 .26 11.56 12.76 0.8519
s-NN27 (%) 10.97 10.43 1.71 2.54 29.92 29.05 0.6844
s-NN20 (%) 20.6 18.6 4.61 7.09 42.4 38.5 0.8176
SDNN (ms) 69.92 65.82 31.88 39.83 108.4 96.97 0.2579
SDNNI (ms) 42.58 42.62 18.79 27.1 61.38 69.55 0.7836
r-MSSD (ms) 19.4 18.04 10.54 11.74 36.27 41.31 1.0000
SDANN (ms) 52.0 51.25 24.11 21.96 85.18 70.96 0.1838
Table 3. Short-term frequency-domain HRV parameters in control and treated (betamethasone) group
Active state Resting state
Control Treated P Control Treated p
HF (ms2) 318.75 (15.80–2251.78) 252.12 (12.77–911.21) 0.3242 51.92 (14.69–184.32) 58.31 (9.20–166.71) 0.7853
HF (n.u.) 0.48 (0.20–0.99) 0.42 (0.19–2.26) 0.3478 0.18 (0.08–0.31) 0.17 (0.07–0.30) 0.8204
LF (ms2) 263.61 (14.48–2246.17) 402.24 (42.73–1185.95) 0.7424 263.61 (14.48–2246.17) 402.24 (42.73–1185.95) 0.8916
LF (n.u.) 0.52 (0.01–0.80) 0.61 (0.24–2.03) 0.1522 0.82 (0.69–0.92) 0.83 (0.70–0.93) 0.8204
VL (ms2) 79.96 (8.63–1482.97) 147.68 (8.87–170.47) 0.3981 317.36 (47.01–899.14) 214.62 (55.83–1030.80) 0.0565
Total power (ms2) 857.90 (38.91–3612.32) 818.24 (75.00–2967.94) 0.4668 791.37 (157.43–1495.71) 618.09 (150.45–1623.06) 0.2288
LF/HF 1.06 (0.32–4.30) 1.38 (0.32–4.30) 0.2699 4.47 (2.24–11.68) 4.82 (2.34–13.08) 0.8204
Values are given as medians (range).
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DISCUSSION
We have shown that cardiac autonomic system balance is
preserved in the neonate after a single course of antenatal
maternal betamethasone treatment for fetal lung maturation in
pregnancies at risk for preterm delivery.
There is experimental evidence that intrauterine exposure to
synthetic glucocorticoids affects balance and activity of the
autonomic cardiovascular system. In adult male guinea pigs
with repeated prenatal exposure to dexamethasone, arterial
blood pressure was significantly elevated (28). Even a single
course of glucocorticoid treatment produced a sustained ele-
vation of blood pressure and altered baroreceptor heart rate
response in fetal sheep and the baboon (29–32) and increased
central and peripheral vascular resistance (29,30,33). How-
ever, others only found transient hypertension after maternal
dexamethasone treatment in fetal sheep (34). In the nonhuman
primate, multiple antenatal dexamethasone exposure resulted
in elevated systolic and diastolic blood pressure at the age of
12 mo (35).
The connection of prenatal glucocorticoid treatment and
increased blood pressure in the human is less clear. In the
neonate (36) and in a cohort of preterm children at the age of
14 y (37), blood pressure was significantly increased, whereas
other data have shown that blood pressure alterations may
rather be transient and normalize within the first few weeks of
life (38). Large follow-up studies did not find significant
alterations in blood pressure in nonstrained conditions at the
age of 20 and 30 y (10,11).
Data addressing more specifically the cardiac autonomic
system reveal persistent abnormalities of cardiac noradrener-
gic innervation after intrauterine exposure to exogenous ste-
roids in the rat (6) and alterations of cardiac intracellular
-adrenoceptor signaling (7). Furthermore, centrally located
systems involved in cardioregulation such as the brainstem
norepinephrine system seem to undergo premature maturation
in response to prenatal synthetic glucocorticiod exposure (39).
There is some evidence that betamethasone may even have a
direct effect on the cardiac pacemaker (40,41). It has been
shown that infants with antenatal betamethasone treatment
display a significant increase in heart rate in response to a
stressor when compared with control infants (5).
To our knowledge, a systematic analysis of HRV parame-
ters according to standardized methods (17) so far has not
been performed in individuals exposed to prenatal glucocor-
ticoid treatment. HRV is a well-established noninvasive mea-
sure of cardiac autonomic control that has been shown to be
related to hypertension (12,13) and to predict future adverse
cardiovascular events in adults (42). HRV analyses have been
suggested for putative prognostic use in children (43). We did
not find significant alterations of any HRV parameter analyzed
in neonates after antenatal betamethasone treatment. Studies
measuring intrauterine FHR variation after steroid administra-
tion have produced inconsistent results. Mulder et al. (3),
analyzing FHR short-term and long-term variation, found
reductions in FHR variation after maternal betamethasone
administration. In contrast, treatment with dexamethasone
resulted in a significant rise in short-term FHR variation (4).
However, both effects were only transiently observed.
We conducted our study in the neonatal period because our
aim was to find out whether putative intrauterine steroid
effects ultimately transform into permanent postnatal alter-
ations of the cardiac autonomic system and to exclude post-
natal-induced influencing factors of system adaptation. This
aspect is even more important in consideration that diseases
susceptible to intrauterine origin such as hypertension and
type 2 diabetes will exhibit multiple system alterations at the
time when they become apparent. For the development of
prevention programs for arterial hypertension and type 2
diabetes, the initiating systems have to be identified and
discriminated from systems secondarily affected. In this study,
putative short-term effects could be excluded as the median
interval between betamethasone treatment and delivery was
more than 7 wk. Our findings provide new evidence that at the
level of the cardiac autonomic subunit, at least, a single course
of betamethasone does not primarily affect sympathetic car-
diac balance.
As early effects may only become apparent during events
with increased demand for adaptive regulation, we supple-
mented our electrophysiological studies with a neuroendocri-
nological approach by analyzing salivary -amylase levels
during resting conditions and after a stressful stimulus. Sali-
vary -amylase is secreted by acinar cells in the salivary
glands that are richly innervated by both sympathetic and
parasympathetic nerve fibers, influencing the release of
-amylase by classic neurotransmitters (44). Studies in hu-
mans and animals have suggested that the activation of the
autonomic nervous system leads to a high activity of salivary
-amylase (25,45–47). Furthermore, -amylase levels have
been found to be associated with cardiovascular physiology
and are suggested to be a surrogate for cardiovascular auto-
nomic system balance (26). Bosch et al. (14) found a signif-
icant negative correlation between the parasympathetic-
influenced HRV parameter RMSSD and -amylase levels
during stress induction in adults. Furthermore, a positive
correlation between -amylase levels and LF/HF as surrogate
for sympathetic tone has been shown (15), thereby making this
parameter a promising indicator for cardiac autonomic func-
tion. Although studies on cardiovascular autonomic physiol-
ogy using -amylase measurements have not been validated in
neonates, several analyses from children support the strong
relationship between salivary -amylase and sympathetic/
parasympathetic nervous system activation in younger indi-
viduals (26). Interestingly, we found stimulated -amylase
levels in betamethasone-exposed neonates rather decreased
when compared with controls although statistical significance
was only marginal (p  0.045). One rather had expected
increases in -amylase levels as response to an increased
sympathetic stress reaction if betamethasone treatment had
affected the system.
The slightly attenuated -amylase response might be ex-
plained by previous findings about the stress-regulating hypo-
thalamo-pituitary-adrenal (HPA) axis. Indeed, we and others
have shown that a single course of antenatal betamethasone
administration causes sustained suppressive effects of HPA
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reactivity in these infants (5,22,48). We speculate a nonsig-
nificant increase in -amylase levels may be the result of
inadequate HPA system sensitivity rather than direct effects of
steroid exposure on the sympathetic system because these
systems are closely interconnected. A stepwise multiple re-
gression was conducted to exclude putative influencing factors
such as gestational age at steroid administration, newborn
weight, and gestational age at delivery, not revealing a signif-
icant influence on -amylase results.
We analyzed a relatively homogenous collective excluding
isolated effects of severe prematurity, pregnancy complica-
tions such as intrauterine growth restriction or preeclampsia in
addition to maternal substance abuse and diseases. Neverthe-
less, although not statistically significant, there was a differ-
ence of 15 d in gestational age between the control and the
treatment group. This may, even though near or at term, entail
a difference in perinatal maturation with a putative influence
on the cardiac autonomic system. It has been shown that with
increasing maturation of the sympathetic nervous system dur-
ing the course of pregnancy, there is a shift of the sympathetic/
parasympathetic balance toward parasympathetic tone (49–
51). The time-domain parameter RMSSD has been shown to
demonstrate highest correlation to gestational age (51), and for
frequency-domain parameters, gestational age-dependent al-
terations of LF and HF parameters have only been found to be
significant during resting and not during active states (49).
Therefore, we analyzed our data for a putative influence of
gestational age on these parameters and conducted a regres-
sion analysis. We found adjusted R-squared values for
RMSSD of 0.10, for LF/HF (resting state) of 0.00, and for
LF/HF (active) of 0.02, indicating no relevant effect of the
difference in gestational age in our groups. Thus, our data
strongly support the notion that at least the cardiac autonomic
subunit of the sympathetic system is not permanently affected
in utero by antenatal steroid treatment for lung maturation.
It is important to note that the sympathetic nervous system
is composed of multiple function-specific subunits (52) and
the programming of sympathetic nervous system function is
believed to occur regionally rather than on a global basis,
suggesting that subdivisions of the sympathetic nervous sys-
tem may be influenced by different sets of environmental
variables (53), thus aspects such as vascular bed regulation
may be affected differently.
We cannot exclude that our methods were not sensitive
enough to expose small alterations in cardiac sympathetic
system balance that may only become apparent with increas-
ing system maturation during infant and adolescent develop-
ment. Even though long-term analyses of antenatal steroid
treatment in young adults did not find sympathoadrenergic
connected pathologies (10), these diseases may not be present
until later ages at the time they usually become apparent. In
fact, putative early markers of sympathetic cardiac activation
such as HRV parameters have not been applied in these
studies.
In conclusion, despite evidence from animal models, it
seems that the neonatal cardiac autonomic system is primarily
unaffected by a single course of betamethasone treatment for
lung maturation. However, the impact of multiple doses is not
known.
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Discussion and future perspectives 
 
Our research has shown that the development of the HPA axis appears to be vulnerable 
towards antenatal challenge whereas the cardiac SNS may be developmentally more stable.  
In the context of our work, several considerations are to be addressed and current knowledge 
on these topics will be presented. 
 
1. Do antenatal alterations, once established persist during life? 
2. Are there specific time windows for the vulnerability of the systems? 
3. Is there a gender difference? 
4. What happens at the other end of the U-shaped birth weight risk curve? 
5. Are there putative preventive / therapeutic options? 
 
 
Do antenatal alterations, once established persist during life? 
 
Our studies have shown that both intrauterine growth restriction and iatrogenic corticosteroid 
application during intrauterine development result in a blunted reactivity of the HPA axis in 
the newborn (Schaffer, Luzi et al. 2009; Schaffer, Muller-Vizentini et al. 2009). One may 
rather have expected an overreaction of this system in consideration of the activated state 
under unfavorable intrauterine conditions (Economides, Nicolaides et al. 1988; Goland, Jozak 
et al. 1993). Furthermore, a variety of studies in adults with low birth weight have shown 
signs of HPA axis hyperactivity either by measuring non-stimulated or stimulated cortisol 
levels as lately summarized by Kajantie (Kajantie 2006). Thus it appears that the HPA axis is 
subject to functional plasticity during the interval between the initiating event and the 
endpoint. Few studies have analyzed HPA axis development during the first years of human 
life. However, it appears that healthy children dampen their cortisol responses to stress during 
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the first year of life (Gunnar, Brodersen et al. 1996; Larson, White et al. 1998) representing a 
physiologic stress hyposensitive period during development. The finding in our studies of a 
blunted reactivity of the HPA axis towards a stress event may point to an acceleration of HPA 
axis system maturation, putatively cortisol induced (Fowden 1995), that may in consequence 
represent an inadequate developmental time frame for steps of proper HPA axis 
establishment. It has been speculated that stress hyporesponsive periods may be connected 
with the circadian day-night periodicity but this notion could not be confirmed in a later study 
(Gunnar, Brodersen et al. 1996; Larson, White et al. 1998). Data from animal models suggest 
that all levels of the HPA axis may be involved as alterations in adrenal capacity and 
responsiveness to ACTH and alterations in various hypothalamic receptor expression levels 
have been found that may be responsible for a hyporesponsive HPA axis (Rosenfeld, 
Suchecki et al. 1992; Challis, Sloboda et al. 2001; Gardner, Jamall et al. 2004). As such, 
blunted HPA axis responses have been found in sheep fetuses during late gestation after early 
intrauterine stress. The authors demonstrated in these animals a decreased expression of CRH 
in the hypothalamus. Additionally,  the GR receptor in the pituitary and in the adrenal ACTH 
receptor were decreased, thereby impairing HPA sensitivity as well as feedback regulation 
(Challis, Sloboda et al. 2001) Selective analyses of different levels within the feed-back 
control system in the human will provide further insight in HPA axis-dependent blunted stress 
response situations and its conversion into hyperactivity. It is not clear at what time point the 
switch of a hypo-responsive HPA axis towards a hyper-responsive state takes place and which 
levels of the axis are involved. It has been speculated that increased ACTH levels during a 
period of decreased adrenal capacity may prime the adrenal gland to increase its 
responsiveness towards future stressors (Rosenfeld, Suchecki et al. 1992). Other factors, such 
as prostaglandins have been suggested to be involved in adrenal glucocorticoid liberation in 
this context (McMillen, Adams et al. 2001). In summary, intrauterine induced alterations in 
the regulation of the HPA axis leads to a state of early hypo-responsiveness in the newborn 
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which appears to be transformed intro a hyperactivity during postnatal life. The exact 
mechanisms involved are to be further analyzed. 
 
Are there specific time windows for the vulnerability of the systems? 
 
It is obvious that vulnerability of systems may depend upon certain sensitive periods in their 
development. This has most impressively been shown in sheep with a pregnancy duration of 
approximately 150 days, where short term dexamethasone exposure for 48h during early 
pregnancy (day 27) did result in hypertension during adulthood while those animals exposed 
at 64 days remained normotensive and glucose tolerance was preserved in all animals 
(Gatford, Wintour et al. 2000). In contrast, single or repeated doses of betamethasone after 
100 days of gestation induced an altered glucose metabolism and normotensive sheep at 1 
year of age (Moss, Sloboda et al. 2001). Likewise, alterations of the HPA axis responsiveness 
have been observed after glucocorticoid exposure during late gestation (day 104-125) but not 
when exposure happened during early gestation (day 25-45) (Moritz, Butkus et al. 2002; 
Sloboda, Moss et al. 2007). Vulnerable periods of systems in the human are less well defined. 
One may speculate that early- vs. late intrauterine fetal growth restriction as well as early (24 
weeks of gestation) vs. late (33 weeks of gestation) betamethasone exposure induce different 
patterns of risk profiles. Lately, this question has been addressed in an evaluation of the 
historical cohort of the Dutch Winter famine. Interestingly, cardiac disease, body mass index 
and disturbed glucose was especially increased when exposure towards famine had been 
occurred during early gestation as to compared to mid- or late gestation (Ravelli, van Der 
Meulen et al. 1999; de Rooij, Painter et al. 2006; Painter, de Rooij et al. 2006). Thus, it 
appears that unfavorable conditions during early pregnancy may be even more profound. 
Indeed, the periconceptional period has been shown to already impact vascular function in 
adult sheep (Torrens, Snelling et al. 2009).  
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Thus, each phase of intrauterine development is likely to carry different vulnerabilities and 
unfavorable intrauterine conditions may have the potential for variable long-term 
consequences for different organ systems. 
 
Is there a gender difference? 
 
There is evidence from human and animal studies, that gender may be relevant for the 
development of diseases of intrauterine origin. In the rat, a gender specific lowering of insulin 
sensitivity and hyperinsulinaemia has been shown in adult males but not females after 
maternal protein restriction during pregnancy and lactation (Sugden and Holness 2002). 
Others have shown that antenatal glucocorticoid exposure resulted in gender specific 
cardiovascular and metabolic physiology alterations as male rats exhibited increased ACTH, 
corticosterone, postprandial insulin-glucose ratios and hepatic gluconeogenic enzyme 
expression while female rats were hypertensive displaying a renin-angiotensin system 
activation (O'Regan, Kenyon et al. 2004). In the adult pig, low birth weight is associated with 
increased cortisol responses to hypoglycaemia in both genders but involves specific changes 
in the female adrenal and male hypothalamic-pituitary region (Poore and Fowden 2003). 
Differential vulnerability of glucocorticoid receptor expression in the hippocampus, 
hypothalamus and pituitary has been suggested (Matthews 2000; Seckl 2004) and it appears 
that females may be more sensitive towards HPA axis programming than males (Weinstock, 
Matlina et al. 1992; McCormick, Smythe et al. 1995). On the other hand, juvenile males have 
been shown to be more sensitive towards antenatal glucocorticoids than females at the level of 
the pituitary and adrenal in the guinea pig (Owen and Matthews 2007). Associations between 
LBW and increased HPA axis activation have not been found to be different in adult men and 
women albeit the female HPA axis appears to be generally more responsive than the male 
(Reynolds, Walker et al. 2005). However, in a cohort of 7-9 year old children, boys born with 
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a low birth weight exhibited raised arterial pressure and systemic vascular resistance, 
particularly after strain while this association was not found in girls. The girls instead 
exhibited increased cardiac sympathetic nervous system activation when born LBW. At the 
same time, cortisol responses to a psychiological stress test was inversely correlated with birth 
weight in boys but not in girls (Jones, Beda et al. 2005; Jones, Godfrey et al. 2005). In a 
cohort of Australian low birth weight adults, signs for cardiovascular autonomic control were 
altered in women but not in men (Jones, Beda et al. 2007). Gender differences in the 
association between birth weight and total cholesterol have been found (Lawlor, Owen et al. 
2006). We did not find gender differences in our studies in neonates, however, it seems that 
gender-specific cortisol reactivity in general depends on different levels of corticosteroid-
binding globulin and sex steroids and therefore gender-specific hormonal influences may 
manifest later during adolescence and adulthood (Kudielka, Buske-Kirschbaum et al. 2004). 
In fact, environmental or nutritional factors have been suggested to lead to gender specific 
epigenetic modulation of gene expression profiles through gender-specific methylation of 
CpC regions and histone modifications (Gabory, Attig et al. 2009). 
 
What happens at the other end of the U-shaped birth weight risk curve? 
 
A variety of studies have reported an U-shaped relationship between birth weight and the risk 
for metabolic disorders. Excessive energy supply and hyperinsulinaemia may equally 
constitute an unfavorable intrauterine environment. Accordingly, large for gestational age in 
combination with maternal gestational diabetes has been shown to demonstrate a significant 
risk factor for the development of the metabolic syndrome in adolescence (Boney, Verma et 
al. 2005). Similar results have been found in a Chinese population (Wang, Liang et al. 2007). 
A meta-analysis including 14 studies confirmed a U-shaped relation between birth weight and 
subsequent risk of type 2 diabetes (Harder, Rodekamp et al. 2007). Furthermore, increased 
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systolic and mean arterial pressure has been found in adolescent offspring of diabetic 
pregnancies (Silverman, Rizzo et al. 1991; Bunt, Tataranni et al. 2005).  
 
The mechanisms underlying these findings are under investigation and experimental evidence 
suggest that insulin and leptin exert dominant influences on central energy-regulating neural 
networks involving hypothalamic regions (Muhlhausler, Adam et al. 2006). Indeed, early 
overfeeding in rats resulted in a resistance towards insulin and leptin of central hypothalamic 
regions involved in regulation of feeding behaviour and thus body weight (Davidowa and 
Plagemann 2000; Davidowa and Plagemann 2007). Interestingly, it has recently been shown 
in the rat that early overfeeding induced a functional alteration in DNA methylation of the 
hypothalamic gene promoter of the anorexigenic neurohormone proopiomelanocortin that is 
involved in the regulation of food intake and body weight by insulin and leptin mediation 
(Plagemann, Harder et al. 2009).  
 
There is strong evidence, that renal and vascular mechanisms are additionally involved. As 
such, intrauterine exposure to hyperglycemia did result in a significant reduction in the 
number of nephrons in the rat offspring (Amri, Freund et al. 1999). Furthermore, macrosomic 
newborns of diabetic mothers displayed an increased aortic intima-media thickness as 
compared to controls (Akcakus, Koklu et al. 2007) and there is evidence for precocious 
artherosclerosis (Skilton 2008).  
Hyperglycemia has been shown to significantly decrease angiogenesis in the chicken embryo 
putatively involving apoptosis and impaired response to pro-angiogenic factors (Larger, 
Marre et al. 2004; Di Marco, Alam et al. 2008) and adult male rats of diabetic pregnancies 
exhibited a permanent decrease of vascular nitric oxide (NO) dependent vasodilatation 
(Rocha, Gomes et al. 2005). 
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Lately, it has been shown in the mouse model that diet induced obesity had persistent effects 
on cardiovascular and metabolic function in the offspring such as hypertension and an 
abnormally high heart rate with signs indicative for endothelial dysfunction and diminished 
baroreceptor sensitivity (Samuelsson, Matthews et al. 2008). Whether the cardiac sympathetic 
nervous system is involved in these effects is currently under investigation. 
 
Are there options for reversibility / therapeutic strategies? 
 
As regulating systems such as the HPA axis contain a certain degree of plasticity during 
postnatal development (Gunnar, Brodersen et al. 1996; Larson, White et al. 1998), the 
question arises as to whether intrauterine induced unfavorable phenotypic effects may be 
reversed during the postnatal development. Indeed, the HPA axis appears to be a biological 
substrate for the interaction of prenatal and postnatal events. As such, repeated maternal 
restraint during the last week of gestation in rats produced a prolonged stress-induced cortisol 
response in the adult offspring. Interestingly, when offspring were raised by a foster mother, 
adoption at birth completely reversed the effects of prenatal stress. These findings were 
associated with rescued mineralocorticoid receptors in the hypothalamus probably restoring 
negative feedback mechanisms (Maccari, Piazza et al. 1995). Adoption has been shown to 
enhance maternal behavior towards the pub as compared to the biological mother.  
In fact, epigenetic alteration of a hippocampal glucocorticoid receptor gene promoter has been 
shown to occur as a result of increased licking and grooming during the neonatal period of the 
rat undermining the theory of behavioral programming during this time through 
glucocorticoid receptor expression (Weaver, Cervoni et al. 2004).  
However, one has to consider that in species such as the rodent important steps of 
neuroendocrine development occurs in the postnatal period while in primates, sheep and 
guinea pigs major brain growth and neuroendocrine maturation happens in utero (Dobbing 
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and Sands 1979; Matthews 1998; Challis, Matthews et al. 2000; Dent, Smith et al. 2000). 
Accordingly, manipulations may occur during different stages of neuroendocrine 
development depending on the species that is being analyzed.  
Nevertheless, even in the mature adult brain of the rat, epigenetic programming and thus 
phenotype could be shown to be reversible by treatment with Trichostatin A a Histone 
deacetylase inhibitor triggering active genomic demethylation (Ou, Torrisani et al. 2007). As 
such, Trichostatin A administration was able to completely reverse maternal induced 
hyperreactivity of the HPA axis in the adult offspring and this was accompanied by a 
significant increase in hippocampal glucocorticoid receptor levels pointing to a restored 
negative feedback mechanism (Weaver, Cervoni et al. 2004). On the other hand, methionine 
treatment resulting in increased methylation of the glucocorticoid receptor promoter produced 
the pathologic phenotype in previously healthy adult rats (Weaver, Champagne et al. 2005). 
Thus it has been suggested that dietary changes in methyl contents may effect epigenetic 
programming (McGowan, Meaney et al. 2008). 
 
Several studies have provided evidence for a putative beneficial effect of leptin-level 
manipulations. This adipokin, as described above, is involved in hypothalamic regulation, 
food intake and energy expenditure and is believed to be significantly involved in the 
perinatal programming of the metabolic syndrome. As such, neonatal leptin treatment 
prevented development of the metabolic syndrome in a model of maternal undernutrition in 
the rat offspring (Vickers, Gluckman et al. 2005). Likewise, leptin supplementation during the 
first 10 days of life partially reversed the IUGR phenotype of the low birth weight piglet 
(Attig, Djiane et al. 2008). Adversely, supplementation of ώ3 fatty acids during postnatal 
nutrition prevented hyperleptinaemia and hypertension in the adult offspring of 
dexamethasone treated rats (Wyrwoll, Mark et al. 2006). Apparently, leptin effects are 
complex and they have been shown to be especially sensitive to pre- and postnatal nutritional 
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status (Vickers, Gluckman et al. 2008). Clearly, further studies are required to ascertain the 
exact role of leptin in these settings.  
 
 
Accumulating knowledge on possibilities to restore a misrouted organism towards normal 
balance gives rise to the hope that early interventions, including behavioral and nutritional 
strategies, may ultimately be able to prevent, reverse or at least alleviate the burden of the risk 
to develop diseases of intrauterine origin in later life. 
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